Chronic Inflammation as a Contributing Cause of B Cell Decline in Aging

Proven Vitamin supplements to obtain Nitric Oxide Health


Browsing for unsurpassed approved products?  Learn about  Cardio Cocktail Medically Certified Products.

B cells are important to the coordination of the immune response. Dysfunctional B cells emerge with age, however, leading to autoimmunity and contributing to immunosenescence, the name given to the general age-related decline in effectiveness of the immune system. Animal studies have shown that selective destruction of the entire B cell population is beneficial in older individuals, improving the immune response: the cells are quickly replaced, but the harmful portion will take much longer to reemerge. Setting all of this to one side, the open access review here is largely focused on more subtle changes in the B cell population and its production in the bone marrow, driven by the effects of age-related chronic inflammation on stem cells and progenitor cells.


The alterations of the B-cell compartment in aging have been evaluated by contrast to B-cell physiology in young adults. Overall, B-cell generation and function demonstrate large similarities between young mice and humans. In the more detailed mouse context, B cells arise from uncommitted progenitors nested in the bone marrow. Overall, aging disturbs B-cell development in the mouse bone marrow. Strikingly, aging seems to introduce a high mouse-to-mouse variability in early progenitor B cellularity compared to young mice. Impaired B-cell development occurs as a result of affected RAG and SLC expression, as well as decreased sensitivity to IL-7 signals. The in-depth situation in humans remains to be established. Nevertheless, available studies suggest that the amount of B cells decreases, although proportions of progenitor and mature B subpopulations may not be substantially changed in the aged bone marrow.

Various clues point at a role for inflammation in the altered B-cell development in aging, albeit the data is generally based on similarities with acute inflammatory responses. Indeed, pro-inflammatory senescent cells as well as terminally differentiated CD8+ effector T cells accumulate in the bones of old mice and humans respectively. Correspondingly, concentrations of pro-inflammatory molecules or their production by cells are increased in bone marrow during aging. The balance between the negating effects of anti-inflammatory cytokines and the intensity, as well as variety, of pro-inflammatory molecules expressed could contribute to the observed variability in the deterioration of early B-cell development in susceptible aged organisms.

Inflammation can affect the differentiation of multi-lineage hematopoietic progenitors. Thus, aged mouse and human hematopoietic stem cell (HSC) physiology is altered and the output of this compartment reveals a bias against the production of lymphocytes due to the accumulation of stem cells with a propensity to differentiate into myeloid cells. This limits the production of B cells. Persistent inflammation in aging could also compromise the differentiation of B lineage-restricted progenitor cells. A major effect of aging is the repression in B cells of the expression and/or activity of the transcription factors E2A and EBF1, which control the RAG and SLC genes.

Despite the alteration of the B-cell compartment in the bone marrow, the cellularity of mature B cells in the spleen is comparable between aged and young mice. However, this apparent stability masks underlying disparities in the distribution of mature B-cell subsets. The situation in humans appears more difficult to appreciate, since most studies performed analyses based on blood samples, which have an inherent variability and may not reflect mature B-cell representation within tissues. Altogether, the B-cell fraction in the blood of elderly people appears decreased and the proportions of naïve and memory subsets altered. Similar to the bone marrow, various inflammatory molecules could influence the distribution of mature B-cell populations.

Link: https://doi.org/10.1159/000501963

Read additional info on N . O . and Cardiovascular physical health.

Read More

Fight Aging! Newsletter, October 14th 2019

Great Supplements regarding Heart


Seeking unsurpassed certified quality supplements?  Learn about  these quality Medically Recognized Products.

Fight Aging! publishes news and commentary relevant to the goal of ending all age-related disease, to be achieved by bringing the mechanisms of aging under the control of modern medicine. This weekly newsletter is sent to thousands of interested subscribers. To subscribe or unsubscribe from the newsletter,
please visit:
https://www.fightaging.org/newsletter/

Longevity Industry Consulting Services

Reason, the founder of Fight Aging! and Repair Biotechnologies, offers strategic consulting services to investors, entrepreneurs, and others interested in the longevity industry and its complexities. To find out more: https://www.fightaging.org/services/

Contents

  • Data on Exercise as a Treatment for Age-Related Arterial Stiffness
  • The Many Roles of Senescent Cells
  • The SENS Research Foundation on the Beneficial Nature of Senolytic Therapies
  • Lipid Metabolism in Aging and Age-Related Disease
  • Is Displaced Nuclear DNA a Meaningful Cause of Chronic Inflammation in Aging?
  • An Interview with Sergey Young of the Longevity Vision Fund
  • Reduced Levels of TOM1 as a Proximate Cause of Neuroinflammation in Alzheimer’s Disease
  • The Search for Factors in Young Blood that Might be Used to Treat Aging
  • Combining Strategies to Slow Aging to Increase Life Span in Flies by 48%
  • Deletion of p38α in Neurons Slows Neural Stem Cell Decline and Loss of Cognitive Function in Mice
  • Mitochondrial Mutator Mice May be a Poor Model
  • An Interview with Amutha Boominathan of the SENS Research Foundation
  • An Interview with Justin Rebo of BioAge
  • The Upheaval in Alzheimer’s Research and Clinical Development
  • Investigating the Superior DNA Defenses of Tardigrades

Data on Exercise as a Treatment for Age-Related Arterial Stiffness

https://www.fightaging.org/archives/2019/10/data-on-exercise-as-a-treatment-for-age-related-arterial-stiffness/

In addition to its effect on muscle growth, exercise upregulates a range of maintenance processes, such as autophagy, that improve tissue function when maintained over the long term. Lack of exercise in later life accelerates the decline in muscle mass and strength, an issue that appears reversible to a degree that might surprise most people. A similar situation occurs with respect to stiffening of blood vessels, in that while much of this depends on mechanisms such as cross-linking and presence of senescent cells, some of the decline is a matter of being sedentary.

The interesting finding in the open access study noted here is that while long term physical exercise is associated with lower blood pressure and lesser degrees of arterial stiffness, having sedentary people undertake short term exercise programs doesn’t help in this matter. This can be compared with other studies in which exercise very rapidly improves matters, such as in the case of memory function.

We can speculate as to what this tells us about the importance of various different causes of arterial stiffness, and the authors of the paper do just that. For our part, we might also think of this in the context of data that shows interventions such as nicotinamide riboside and MitoQ, approaches that improve smooth muscle cell function, act to reduce arterial stiffness somewhat. Smooth muscle is the tissue responsible for contraction and dilation of blood vessels, and some fraction of stiffness arises from dysfunction in this tissue. One would certainly expect exercise to act through a similar improvement in smooth muscle function, but apparently that isn’t the case in the short term.

Exercise and Arterial Stiffness in the Elderly: A Combined Cross-Sectional and Randomized Controlled Trial (EXAMIN AGE)


Cardiovascular diseases are responsible for the majority of deaths in western countries and age has been identified as a main risk factor. Vascular tissue biomarkers such as arterial stiffness (AST) provide a means of optimized risk assessment to detect individual subclinical organ damage. Commonly measured as central pulse wave velocity (PWV), AST has gained clinical importance and has been proven to be a reliable predictor for cardiovascular (CV) risk in the general population. Altered PWV indicates subclinical target organ damage and may be used to quantify cumulative damaging effects of CV risk factors on the aging arterial wall integrity.

Previous studies on the effect of regular physical activity and exercise on indices of AST in the elderly have reported conflicting results. High-intensity interval training (HIIT) is an exercise modality that has attracted attention for its potency to increase cardiorespiratory fitness and reduce CV risk in patients, for example, with metabolic syndrome. Data on HIIT and its effects on PWV are scarce. Previous evidence suggests that HIIT may be superior regarding reductions in AST compared to moderate aerobic training in young patients with increased CV risk. However, a recent meta-analysis could not detect differences in AST reduction between the two training regimens.=

Our aim was to investigate the associations between long-term physical activity and central PWV in healthy and diseased elderly. Our study results demonstrate the importance of long-term physical activity and the limited impact of short-term exercise training on large artery stiffness in an older population. Long-term physical activity was associated with lower central PWV even in the absence of CV risk factors. Most importantly, 12-weeks of HIIT did not reduce PWV in elderly at increased CV risk.

Aging is characterized by continuous remodeling of the arterial wall, and higher cardiorespiratory fitness may mitigate stiffening of the aging arterial tree. In our study, with every 10 ml/min/kg increase in VO2max, PWV dropped by 0.8 m/s. Active participants presented with 0.5 m/s lower central PWV than their sedentary counterparts. An increase of 1 m/s in central PWV has been associated with a 15% risk increase in CV and all-cause mortality. Thus, our cross-sectional findings indicate an 8% risk increase attributable to a sedentary lifestyle even in healthy elderly.

Our results demonstrate that long-term active compared to sedentary lifestyle is associated with lower AST even in healthy elderly. This suggests that age- and disease-related vascular stiffening and the associated worse CV outcome can be postponed by long-term regular physical exercise. Short-term exercise, even at higher intensities, cannot improve arterial stiffening in sedentary elderly with increased CV risk. Exercise-induced reductions of AST seem to depend on a concomitant decrease of blood pressure.

The Many Roles of Senescent Cells

https://www.fightaging.org/archives/2019/10/the-many-roles-of-senescent-cells/

Long-lived senescent cells accumulate with age, initially quite slowly as they are efficiently removed by the immune system when their own programmed cell death processes fail, but once the immune system starts to decline with age, the burden of cellular senescence ramps up dramatically. Senescent cells secrete a potent mix of signals known as a senescence-associated secretory phenotype (SASP). It spurs chronic inflammation, destructively remodels nearby tissue, encourages nearby cells to also become senescent, and causes all sorts of other issues as well. It is very harmful, and the more senescent cells there are, the worse the consequences.

Fortunately, the research and development communities have finally woken up to the fact that senescent cells are an important contributing cause of aging. Numerous animal studies have demonstrated rejuvenation, reversal of specific age-related conditions and measures of aging, via the targeted destruction of senescent cells, using senolytic therapies of one form or another. Human trials of first generation senolytics are underway and the first results were published this year. Some of those compounds are cheap and readily available, and we might hope that they will be pushed into the clinic quite soon as people realize just how beneficial they might be. Meanwhile, startup biotech companies are developing what will hopefully be better second generation treatments, to arrive in the clinic in the years ahead.

Senescent cells do actually have a number of beneficial purposes. They are involved in regeneration from injury, in suppression of cancer, and embryonic development. Fortunately all of these are short-term roles, and thus do not conflict with a strategy of periodic clearance of lingering senescent cells. A senescent cell in its proper time and place emerges, does its job, and then is destroyed quite soon thereafter. It is the few that stick around for the long term that are the problem, and destruction is the most straightforward approach to take; it aligns with the outcome that our biochemistry attempts for all senescent cells,but fails for the lingering few.

Cellular senescence in development, regeneration and disease


Cellular senescence is a form of permanent cell cycle arrest that can be induced in primary cells in response to a variety of stimuli. Senescence was first discovered in primary cells that were grown for extended periods in culture, reaching what became known as a state of replicative senescence, the cellular equivalent of old age. Subsequently, it was shown that cells exhibiting markers of senescence accumulate in aging tissues, further linking the senescence process with aging. Later, a landmark study identified that the expression of active oncogenes (such as those encoding mutant Ras) in primary cells could induce senescence prematurely, in a process now known as oncogene-induced senescence (OIS). This introduced the concept that senescence might function as a tumor-suppressive mechanism to block the aberrant proliferative effects of oncogenic mutations in cells.

Following on from this, many diverse stress-inducing stimuli including irradiation, chemotherapy, cytokine treatment and even induced pluripotent stem cell(iPSC) reprogramming have been shown to induce a senescent response in a variety of cell types. In summary, senescence functions as a cellular process that prevents the proliferation of old, damaged and potentially tumorigenic cells, but the consequence of which is increased aging at the organismal level. Although the regulated induction of senescence is beneficial in preventing tumor formation, prolonged aberrant persistence of senescent cells can have detrimental effects in promoting cancer. For example, if the timely clearance of OIS cells by the immune system is perturbed, this leads directly to tumor formation. Similarly, although chemotherapy can, in part, exert beneficial effects by inducing tumor-cell senescence, the persistence of therapy-induced senescent cells can, via the SASP, promote tumor recurrence and metastasis.

The senescence process has long been linked to aging, including in the original study demonstrating that aging human skin has increased numbers of cells that are positive for the senescence marker senescence-associated beta-galactosidase (SA-ß-gal). In recent years, perhaps the most conclusive data linking senescence with organismal aging has come from the use of senescence ‘deletor’ mouse models, in which cells expressing p16INK4A are selectively targeted for elimination. In such models, the removal of senescent cells results in significant improvements in health and vigor, and also in lifespan. These studies unequivocally demonstrate how the accumulation of senescent cells during aging can have a negative impact on health and lifespan.

Much of what we understand about senescence has been extrapolated from studies of disease or aging. However, more recent discoveries of beneficial roles for senescence in non-disease conditions has helped to create a clearer understanding of the physiological function of senescence. Beneficial roles for senescent cells have been described in various conditions of wound repair. After wounding, the deposition of extracellular matrix (ECM) aids the repair process but, if excessive, can result in fibrosis, which subsequently impairs proper repair. Senescence has been demonstrated to have a role in wound repair and the fibrotic response in a number of tissues.

The discovery of cells exhibiting markers and features of senescence in developing embryos was an exciting finding. This was primarily based on studies describing senescent cells in mouse embryos. However, cells bearing some or many features of senescence have also been described in human embryos. Interestingly, in many cases, senescent cells were found in signaling centres, with the secretory function of these structures contributing to cell fate specification and tissue patterning. The emerging details suggest that senescent cells may have multiple functions in the embryo. Senescent cells that appear in the embryo arise in very precise patterns in time and space, appearing during specific time windows, before subsequently disappearing, demonstrating that the induction, presence and removal of these cells is a tightly controlled programmed cellular process.

Senescence is also intricately linked with cellular reprogramming, with studies of iPSCs providing key clues. Indeed, expression of the four reprogramming factors Oct4, Sox2, Klf4, and Myc (OSKM) causes widespread induction of senescence markers in cells that ultimately do not undergo reprogramming, whereas those that successfully reprogram manage to silence key senescence mediators. Interestingly, induction of reprogramming in tissues also activates a senescence response, but in cells adjacent to those that undergo reprogramming. It appears that the SASP, and in particular IL6 from the senescent cells, enhances OSKM activity and reprogramming in nearby cells.

The SENS Research Foundation on the Beneficial Nature of Senolytic Therapies

https://www.fightaging.org/archives/2019/10/the-sens-research-foundation-on-the-beneficial-nature-of-senolytic-therapies/

The SENS Research Foundation should need no introduction to this audience, but, just in case, this is one of the few non-profit organizations dedicated to advancing the state of the art in rejuvenation research and development. The focus of the SENS Research Foundation staff is on unblocking lines of research that are presently moving too slowly, rather than on reinforcing success. The co-founder, Aubrey de Grey, assembled the Strategies for Engineered Negligible Senescence (SENS) going on twenty years ago. It was, and is, a synthesis of what is known in the research community regarding the root causes of aging. In the SENS model, a cause of aging is a form of damage that occurs and accumulates as a result of the normal operation of cellular metabolism.

Among these causes of aging is the accumulation of senescent cells, cells that should be destroyed, but linger to cause harm via their inflammatory signaling. It took more than a decade for the SENS proposal that senescent cells should be targeted for destruction to emerge as a well supported line of research, and that required a great deal of advocacy and bootstrapping behind the scenes. The field has advanced considerably since then, and at an accelerating pace. Today, numerous biotech companies are developing what have come to be known as senolytic therapies, capable of selectively destroying senescent cells. There is overwhelming evidence from animal studies for senolytics to be beneficial – to extend healthy life, and more importantly to significantly turn back age-related disease and dysfunction at a late stage. This year, the first clinical trials provided initial data to show that senolytic therapies should function in the same way in humans.

On occasion, the SENS Research Foundation staff publish answers to questions from the community. This month, the topic is clearance of senescent cells, and whether not it is an unalloyed benefit. Is there any reason we should hold back from periodically clearing all lingering senescent cells in old tissues? The animal data so far suggests few caveats; the downsides remain largely theoretical rather than actual, while the upsides are self-evident. The essay is well supported by references; you should read it all, not just the excerpt shown here.

Question of the Month: Senolytics – Solution or Self-Defeating for Senescent Cells?


This month’s question from the community: when senolytic drugs cause senescent cells to die, other (younger) cells need to divide and take the place of the dead cells. This cell division causes telomere shortening, thus possibly creating new senescent cells. How is it that the process of killing senescent cells is not self-defeating if new senescent cells are being created?

There are a couple of ways to come at this question. The first is to just look at the astonishing beneficial effects of senolytic drugs or gene therapies in aging mice and mouse models of age-related disease. In these studies, senolytic drugs have restored exercise capacity and capacity to form new blood and immune precursor cells in aging mice to near youthful norms, while preventing age-related lung hypofunction, fatty infiltration into the liver, weakening or failure of the heart, osteoporosis, and hair loss. These treatments have also prevented or treated mouse models of diseases of aging like osteoarthritis, fibrotic lung disease, nonalcoholic fatty liver disease, atherosclerosis, cancer and the side-effects of conventional chemotherapy, as well as neurodegenerative diseases of aging like Parkinson’s and Alzheimer’s diseases … and on and on! So whatever collateral damage might ensue from ablating senescent cells, it’s pretty clear that senolytic treatments are doing a lot more good than harm.

But let’s drill down on the underlying reasoning of the question a little more. Suppose (as the question posits) that every time you destroy a senescent cell, a progenitor cell (one of the partly-specialized tissue-specific cells that repopulate a tissue with mature cells specific to that tissue) replicates to create a new cell to take its place. In fact, studies do show that when senescent cells are killed in a tissue, the progenitor cells begin to multiply and/or to function better as stem cells. This benefit is not due to the progenitor cells automatically replicating themselves and taking the place of the senescent cell, but because the baleful secretions spewed out of senescent cells inhibit the progenitor cells’ regenerative function, such that destroying senescent cells allows the progenitor cells to begin working properly again. This is observed in blood-cell-forming cells, cardiac progenitor cells, bone-forming cells, and the cells that form new fat cells – in both mice and now (in a small, short-term clinical trial) even in humans!

So does this support the worry behind the question? Not really. It just takes a moment’s thought to realize that just one such replication can’t possibly be enough to drive a stem/progenitor cell into senescence. Still, even if a single round of senolytics isn’t enough to drive your stem cells senescent, what if you turn one tissue stem cell senescent for every two times they are triggered to proliferate by senolytic therapy – or every three, or four, or ten? Might a single round of senolytic drugs be a net benefit, whereas repeated treatments over a lifetime would deplete tissue stem cells step by step, eventually riddling the body with senescent cells and leaving the patient (murine or human) worse off over the long term? Fortunately, we have long-term studies to address that question – and they tell us again that the answer is “no.”

Lipid Metabolism in Aging and Age-Related Disease

https://www.fightaging.org/archives/2019/10/lipid-metabolism-in-aging-and-age-related-disease/

Lipids are everywhere in our biochemistry. Where they are present in cell structures and molecular mechanisms that are important to any specific age-related disease, or are among the underlying root causes of aging, it will tend to be the case that differences between species (and possibly individuals) can lead to changes in the pace of aging and disease. For example, lipid composition determines resistance to oxidative damage to cell membranes. A range of evidence supports the membrane pacemaker hypothesis of aging, in that longer-lived species tend to have more resilient cell membranes, based on their lipid composition.

Today’s open access paper uses lipids as an anchoring point for a wide-ranging discussion on aging, biomarkers of aging, and the differences in aging between species. The authors are, I feel, justifiably pessimistic about the prospects for the eventual production of therapies based on most of the means to slow aging demonstrated in short-lived laboratory species. There are indeed radical differences between the biochemistry of short-lived species and long-lived species such as our own. Yet even when mechanisms are in fact proven to be much the same in all of worms, flies, mice, and humans, as is the case for calorie restriction and its upregulation of cellular maintenance processes, we cannot expect that therapies will automatically be effective enough to justify development. The practice of calorie restriction extends life in mice by up to 40%, but while it improves health in humans, it certainly doesn’t significantly extend human life span in the same way.

The role of lipid metabolism in aging, lifespan regulation, and age-related disease


Due to the sheer amount of time and cost required to validate a study in humans, the bulk of our aging and lifespan data come from shorter-lived yeast, worms, flies, and rodents. With the exception of research showing that caloric restriction improves health and survival in rhesus monkeys, little aging work has been done in longer-lived organisms. The bulk of our understanding regarding aging comes from genetic experiments in model organisms, and we do not yet know how similar or dissimilar human aging is. Rather than screen every lifespan-extending intervention in humans to better understand how human aging works, another approach would be to utilize aging biomarkers.

Biomarkers that strongly correlate with aging, lifespan, and healthspan can teach us about which processes are involved in human aging. Ideally, a robust and practical biomarker would be one that incurs a low monetary cost and can be measured safely, repeatedly, and easily. Blood draws are especially appealing because they are inexpensive, simple, low risk, and can be taken as needed throughout a patient’s lifetime. While several biomarker studies have focused on protein-based markers, the advancement of metabolomic techniques has made it feasible to look closely into a large array of metabolites. Metabolomic lipids and lipid-related proteins represent a large, rich source of potential biomarkers that are easily measured in the blood. Compounds in lipid metabolism can take many forms, such as phospholipids, triglycerides, waxes, steroids, and fatty acids. They also play diverse physiological roles, such as forming cell membranes and exerting powerful cell signaling effects. Lipids are perhaps the most well-known for the paramount roles they play in both the storage and mobilization of energy.

Although lipids have been traditionally treated as detrimental and as simply associated with age-related diseases, numerous studies have shown that lipid metabolism potently regulates aging and lifespan. For example, researchers assessed the plasma lipidomic profiles of 11 different mammalian species with longevities varying from 3.5 to 120 years. They found that a lipidomic profile could accurately predict an animal’s lifespan and that, in particular, plasma long-chain free fatty acids, peroxidizability index, and lipid peroxidation-derived product content are inversely correlated with longevity. Evidence from animals with extreme longevity also links lipid metabolism to aging. The ocean quahog clam Arctica islandica, an exceptionally long-lived animal that can survive for more than 500 years, exhibits a unique resistance to lipid peroxidation in mitochondrial membranes. Naked mole rats, which enjoy remarkably long lifespans and healthspans for rodents, have a unique membrane phospholipid composition that has been theorized to contribute to their exceptional longevity.

A plethora of dietary, pharmacological, genetic, and surgical lipid-related interventions extend lifespan in nematodes, fruit flies, mice, and rats. For example, the impairment of genes involved in ceramide and sphingolipid synthesis extends lifespan in both worms and flies. The overexpression of fatty acid amide hydrolase or lysosomal lipase prolongs life in Caenorhabditis elegans, while the overexpression of diacylglycerol lipase enhances longevity in both C. elegans and Drosophila melanogaster. The surgical removal of adipose tissue extends lifespan in rats, and increased expression of apolipoprotein D enhances survival in both flies and mice. Mouse lifespan can be additionally extended by the genetic deletion of diacylglycerol acyltransferase 1, treatment with the steroid 17-α-estradiol, or a ketogenic diet.

In humans, blood triglyceride levels tend to increase, while blood lysophosphatidylcholine levels tend to decrease with age. Specific sphingolipid and phospholipid blood profiles have also been shown to change with age and are associated with exceptional human longevity. These data suggest that lipid-related interventions may improve human healthspan and that blood lipids likely represent a rich source of human aging biomarkers.

Is Displaced Nuclear DNA a Meaningful Cause of Chronic Inflammation in Aging?

https://www.fightaging.org/archives/2019/10/is-displaced-nuclear-dna-a-meaningful-cause-of-chronic-inflammation-in-aging/

Sterile inflammation arises without external cause, such as infection or injury, and chronic sterile inflammation is a characteristic of aging. Inflammatory signaling becomes constant and pronounced in tissues, and the immune system is constantly roused to action. Processes, such as regeneration from injury, that depend upon a clear cycle of inflammation that starts, progresses, and resolves are significantly disrupted. It is no exaggeration to say that the downstream consequences of chronic inflammation accelerate the progression of all of the common age-related conditions. It is of great importance in atherosclerosis and neurodegenerative conditions, for example. Like raised blood pressure, chronic inflammation is one of the more important mechanisms acting to convert the low-level molecular damage at the root of aging into the various proximate causes of age-related disease and mortality.

Thus the research community is greatly interested in understanding how and why sterile inflammation arises in later life. Cellular senescence is one sizable area of investigation, as senescent cells accumulate with age, and secrete inflammatory signals. Additionally, visceral fat tissue acts to increase the pace at which senescent cells arise, but also contributes to inflammation via other mechanisms. In the short open access commentary here, the authors discuss a potential mechanism whereby cells in aged tissues start to eject DNA fragments from the cell nucleus, and this can cause reactions that lead to inflammatory signaling. This is probably important in cellular senescence, but may also operate in other cells.

Damaged DNA marching out of aging nucleus


Subclinical but heightened inflammation in the absence of infection is a key feature of aging, and includes senescent cells that secrete cytokines. Yet, what are the intrinsic processes that initiate ‘inflammaging’, and possibly other forms of sterile inflammation, like autoimmunity? Self-DNA has long been suspected as trigger and target of autoimmunity, as anti-nuclear antibodies, anti-dsDNA (double-stranded DNA) antibodies and plasma DNA are observed in autoimmune patients of lupus and rheumatoid arthritis.

In studying the initiating events leading to autoimmune arthritis in mice deficient for the lysosomal nuclease DNASE2A, we revealed an unexpected ‘hidden’ source of this inflammatory DNA – the cell’s own nucleus. In healthy cells, damaged and irreparable nuclear DNA fragments are trafficked to the cytosol, enclosed by autophagosomes, and delivered to the lysosomes for degradation by DNASE2A. Lacking DNASE2A, extranuclear DNA accumulates in cells and induces inflammation via innate DNA sensing. Cytosolic DNA sensing is activated when dsDNA binds the DNA sensor enzyme cGAS (cyclic GMP-AMP synthase), converting GTP and ATP into the endogenous second messenger cGAMP, which in turns activates the adaptor protein STING (stimulator of interferon genes) and induces innate immune responses and inflammation. Nuclear DNA as a trigger of immunity could help explain a range of inflammatory conditions.

As cells age, damaged DNA accumulates over time. As an interesting aside, anti-dsDNA antibodies are also found at higher levels in older adults. Could damaged DNA march out of the nucleus of an old cell to set off inflammaging? Indeed, in replicative and oncogene-induced senescent cells, damaged nuclear DNA is exported. Clearing DNA is perhaps the most effective way to eliminate its inflammatory danger. As the only known acidic DNA endonuclease, DNASE2A preferentially degrades dsDNA. It resides with the lysosome, where intracellular and extracellular DNA cargoes converge for degradative digestion. In mice, Dnase2a-deficient cells exhibits the typical senescent phenotype of enlarged cells, slow cell growth, and increased expression of aging markers (senescence-associated β-gal activity, p16 and HP1β expression). Indeed, ectopic expression of DNASE2A substantially reduces cytosolic DNA abundance, innate immune activation and cellular aging phenotype in old cells, thus confirming the protective role of enzymatic DNA degradation in limiting inflammation.

Growing evidence now supports a unifying theory that damaged or irreparable DNA leaves the nucleus to drive aging-related inflammation via innate DNA sensing. Where DNA damage is increased (aging), DNA repair inhibited (ataxia), or nuclear barrier compromised (progeria), DNA load may be not reduced promptly or sufficiently, leading to inflammation. So how far can this DNA theory help to understand the cellular immune mechanisms underlying aging? Each nucleus holds a massive reservoir of endogenous DNA that can trigger local and systemic immunity if there are internal abnormalities such as DNA damage. How nuclear DNA export, trafficking, sensing, and degradation is coordinated to maintain cellular homeostasis is largely unknown. DNA danger coming from within generates exciting questions that probe into the basic life cycle of broken DNA fragments, and suggest ways of treating self-DNA-mediated sterile inflammation (autoimmunity, cancer, neurodegeneration, and chemotherapy) by regulating the abundance of mis-localized DNA.

An Interview with Sergey Young of the Longevity Vision Fund

https://www.fightaging.org/archives/2019/10/an-interview-with-sergey-young-of-the-longevity-vision-fund/

The Longevity Vision Fund is the third of the sizable pools of venture funding to emerge of late, after Juvenescence and Life Biosciences, that are dedicated to the new longevity industry. Unlike the other two, the Longevity Vision fund is initially focused on what I would say are initiatives that don’t much matter and won’t much move the needle on human aging. Only in their second phase do they intend to invest in classes of biotechnology and therapy that may include high value approaches.

Despite the way in which senolytics to remove harmful senescent cells outperform everything else to date in reversal of aging and age-related disease, we are still, it seems, somewhat early in the phase of spreading the understanding that repair based strategies are the only real way forward to sizable gains in human health and life span in old age. Aging is damage and repair of that damage is rejuvenation – as a steering principle, this is still not yet widely adopted. As a result a great deal of funding is going to be used on projects that do very little of consequence in the matter of aging. At a conference not so long ago, I mentioned this to a wealth manager, who shrugged and said that there is so much potential funding on the sidelines, tipping towards becoming involved, that it doesn’t much matter – just fund everything with a credible team and let the chips fall where they may.


There so many things that make longevity investment risky. Not only is it subject to all of the translational risks seen in more traditional biotech investing, but we’re also so early on in the game that its hard to tell if any of it will live up to its promise. Let’s say I’m a nervous first-time investor in longevity – you run one of the biggest funds in this space, give me some tips on how you assess risk.

Longevity is a new and exciting field, which does bring certain risks – but at the same time, the potential is unmatched. We are currently undergoing a massive Longevity Revolution, where how medicine is practiced, drugs are developed, is changing. Tech giants are becoming our new healthcare providers. Medicine is becoming more personalized. I am often invited to speak at longevity and private wealth conferences, where investors ask me the same question. I start by explaining my personal “3 Horizons” framework to help map the longevity space: Horizon 1: technology currently available that has the potential to expand our lifespans to 100 years, such as DIY diagnostics, wearables, digital healthcare delivery, medical software and apps; Horizon 2: emerging technology with the potential to expand our lifespans to 150 years, such as genome therapy and editing, stem cell therapy, nano-robots, AI-based diagnostics and drug discovery, smart hospitals; Horizon 3: age reversal, brain-computer integration, avatars, Internet of the Body.

We invest across all three Horizons, but new investors may want to focus on the first two: early diagnostics, AI in healthcare, life extension technologies in general, and therapies addressing age-related diseases. As for dealing with investment risks, it is really important to have access to the scientific and medical expertise in this field, because scientific due diligence is a key part of the investment decision-making.

You’ve recently set up the Longevity Vision Fund. How do you hope to differentiate it from others (Juvenescence has a strong focus on regenerative medicine, for instance)?

Longevity is such a new field for investment that there is room for everybody, which inspires collaboration and exchange of knowledge. As such, we don’t tend to compete or actively differentiate ourselves from others in this field – ultimately, we are all in this together with the same goal of improving health and longevity for humanity. We also love what Juvenescence does in the field – especially their collaborations with the world’s leading scientific hubs. Apart from Juvenescence, we also have other investments, including Life Biosciences and more – and we all share the same vision of extending healthy human lifespans and making the world a better place.

In your upcoming book you’re set to cover the ethical ‘trade-offs’ of extended lifespans. What do you think could be the biggest benefit and the biggest detriment to us all living to 200?

I think the goal is not just to have “extended lifespans” or “to live to 200” (although this is my personal aspiration!) but the improved healthspan, the energy and the wellbeing that we could enjoy into the longer years of our lives. If we look from the perspective of healthy longevity, many detriments commonly associated with longer lifespans, such as an aging population, overburdening the economy, excessive medical costs become irrelevant. Extended healthy longevity means healthier populations, lower medical costs, a more productive workforce, a later retirement. In fact, as an investor, I consider longevity to be the biggest economic opportunity of the century.

Reduced Levels of TOM1 as a Proximate Cause of Neuroinflammation in Alzheimer’s Disease

https://www.fightaging.org/archives/2019/10/reduced-levels-of-tom1-as-a-proximate-cause-of-neuroinflammation-in-alzheimers-disease/

Researchers here provide evidence for lower levels of TOM1 observed in Alzheimer’s disease to be a proximate cause of chronic inflammation in the brain, and suggest that therapies to raise TOM1 levels might dampen inflammation to a great enough degree to be useful to patients. The inflammation and disarray in the brain’s immune system, particularly microglia, is implicated in a range of neurodegenerative conditions. In the case of Alzheimer’s disease it remains debatable as to where neuroinflammation sits in the chain of cause and consequence: is it a result of amyloid-β aggregation, a necessary step that leads to the much more harmful tau aggregation that characterizes the later stages of the condition, or does it also directly cause amyloid-β aggregation? Both might be the case – there are a great many two-way interactions in aging.


As we age, the innate immune system becomes dysregulated and is characterized by persistent inflammatory responses, and the chronic inflammation mediated by inflammatory receptors represents a key mechanism by which amyloid-beta (Aβ) drives the development of cognitive decline in Alzheimer’s disease (AD). A crucial aspect of this process is a failure to resolve inflammation, which involves the suppression of inflammatory cell influx and the endocytosis of inflammatory receptors.

To decipher the mechanism associated with its pathogenesis, we investigated the molecular events associated with the termination of IL-1β inflammatory responses by focusing on the role played by the target of Myb1 (TOM1), a negative regulator of the interleukin-1β receptor-1 (IL-1R1). We first show that TOM1 steady-state levels are reduced in human AD hippocampi and in the brain of an AD mouse model versus respective controls. Experimentally reducing TOM1 affected microglia activity, substantially increased amyloid-beta levels, and impaired cognition, whereas enhancing its levels was therapeutic.

This data shows that reparation of the TOM1-signaling pathway represents a therapeutic target for brain inflammatory disorders such as AD. A better understanding of the age-related changes in the immune system will allow us to craft therapies to limit detrimental aspects of inflammation, with the broader purpose of sharply reducing the number of people afflicted by AD.

The Search for Factors in Young Blood that Might be Used to Treat Aging

https://www.fightaging.org/archives/2019/10/the-search-for-factors-in-young-blood-that-might-be-used-to-treat-aging/

A fair number of research groups and a few startup companies are engaged in the search for factors in young blood that might explain the effects of parabiosis. Heterochronic parabiosis is a procedure in which the circulatory systems of a young and an old mouse are linked. The young mouse begins to show some early signs of aging, and the old mouse shows a reversal of some measures of aging. The evidence to date is conflicted on the topic of whether or not this effect is due to beneficial components of young blood: it is clearly the case that some signals present in young blood can be delivered on their own to old animals in order to produce benefits; yet blood and plasma transfusions don’t seem to work to any meaningful degree in either mice or people; and a very compelling study provided evidence for benefits to result from a dilution of harmful factors in old blood.


Scientists initially used parabiosis to investigate how conjoined organisms, like some twins, affect each other. After a period of declining interest in the method starting in the 1970s, parabiosis returned to the scene in 2005, when scientists decided to use the approach to answer questions about tissue regeneration in older organisms. After the release of the 2005 study and other work showing that young blood could seemingly rejuvenate old mice, scientists and the public alike seized on the alluring notion of an elixir of youth.

In February, concerned about premature application in humans based on findings in mice, the US Food and Drug Administration cautioned against young plasma transfusions, noting that they have “no proven clinical benefit” for age-related or other diseases in humans. In the wake of the initial fervor surrounding young blood, researchers are taking a more measured approach. Rather than trying to reverse aging, they’re identifying the molecular factors responsible for the changes seen in parabiosis experiments in hopes of targeting specific diseases associated with aging.

The relative abundance of aging and regenerative factors in our bodies shifts as we age. At birth, our blood contains more regenerative factors – like oxytocin, which has been shown to rejuvenate skeletal muscle stem cells in mice – than aging factors. But as we get older, that balance gradually tips in favor of aging factors, like the protein eotaxin, thought to play a role in age-related diseases in which systemic inflammation occurs. Aging factors lower our ability to maintain and repair tissue structure and function, while regenerative factors raise it.

Some researchers who study aging think that young blood could point us to more than just regenerative factors for treating disease. Research to slow or halt aging is more complex than searching for regenerative factors in blood. In parabiosis, animals share not only a circulatory system but also their immune and organ systems, making it difficult to rule out these systems’ influence on aging or rejuvenation. Researchers developed a parabiosis-like technique that allows mice to exchange only blood. When the researchers used the technique to connect young and old mice, they found that after each mouse had equal parts old blood and young blood circulating through it, the young mouse displayed negative effects. Old blood drastically decreased hippocampal neuron generation, learning and agility, and liver regeneration in young mice.

Young blood, on the other hand, showed no significant benefits for cognition, agility, or the generation of hippocampal neurons in old mice. In other words, the secret to stalling aging may not lie in boosting rejuvenating factors but instead in blocking factors in old blood that promote aging – ones that hinder tissue maintenance and repair. Researchers have turned their focus to TGF-β, a protein that increases with age. A recent study showed that pharmacologically normalizing the activity of the TGF-β pathway, which is elevated in old age, while adding the rejuvenating factor oxytocin improves muscle regeneration, enhances hippocampal neuron growth, and boosts cognition.

Combining Strategies to Slow Aging to Increase Life Span in Flies by 48%

https://www.fightaging.org/archives/2019/10/combining-strategies-to-slow-aging-to-increase-life-span-in-flies-by-48/

The research and development communities have little incentive to try combinations of approaches when it comes to intervening in the aging process, or indeed to treat any medical condition. There is little funding and large barriers stand in the way of any effort to combine either existing or novel therapies, such as issues with intellectual property rights. Thus few groups undertake such work. Which is a pity, because one would expect there to be synergies between therapies targeting two different mechanisms affecting the same condition in many cases, or at least for the treatments to be additive in effect.

The example here is interesting as a demonstration of such synergies between approaches, but it is worth recalling that the upregulation of stress response mechanisms via nutrient sensing used as a target here is a strategy known to have a far smaller impact on life span in long-lived species than in short-lived species. Extending life in flies by 48% is still not something that would necessarily indicate that any significant gains in human life span are possible via this methodology.


Increasing life expectancy is causing the prevalence of age-related diseases to rise, and there is an urgent need for new strategies to improve health at older ages. In organisms ranging from invertebrates to mammals, reducing the activity of the nutrient-sensing mechanistic target of rapamycin (mTOR) and insulin/insulin-like growth factor signaling (IIS) network can promote longevity and health during aging. Lowering network activity can also protect against the pathology associated with genetic models of age-related diseases. The network contains many drug targets, including mTOR, mitogen-activated protein kinase kinase (MEK), and glycogen synthase kinase-3 (GSK-3). Down-regulation of mTOR activity by rapamycin, GSK-3 by lithium, or MEK by trametinib can each individually extend lifespan in laboratory organisms, and brief inhibition of mTOR has recently been shown to increase the response of elderly people to immunization against influenza.

An advantage of pharmacological interventions is that the timing and dose of drug administration are relatively simple to optimize, and drugs can be easily combined. Here we show that trametinib, rapamycin, and lithium act additively to increase longevity in Drosophila. Because rapamycin, lithium, and trametinib extend lifespan by at least partially independent mechanisms, we investigated the effects on lifespan of their double and triple combinations.

Double combinations of lithium and rapamycin, lithium and trametinib, or rapamycin and trametinib produced a reproducibly greater lifespan extension than controls, on average 30%, compared to each compound alone, which extended lifespan by an average of 11%. Remarkably, the triple drug combination increased lifespan by 48%. Furthermore, the combination of lithium with rapamycin cancelled the latter’s effects on lipid metabolism. In conclusion, a polypharmacology approach of combining established, prolongevity drug inhibitors of specific nodes may be the most effective way to target the nutrient-sensing network to improve late-life health.

Deletion of p38α in Neurons Slows Neural Stem Cell Decline and Loss of Cognitive Function in Mice

https://www.fightaging.org/archives/2019/10/deletion-of-p38%ce%b1-in-neurons-slows-neural-stem-cell-decline-and-loss-of-cognitive-function-in-mice/

Researchers here provide evidence for p38α to be involved in the regulation of diminished neural stem cell activity with age. It is thought that the loss of stem cell activity with age, throughout the body and not just in the brain, is an evolved response to rising levels of damage that serves to reduce the risk of cancer that arises from the activity of damaged cells. The cost, however, is a slow decline into dysfunction and tissue failure. There are many therapeutic approaches under development in labs and startups that involve ways to force stem cell populations to go back to work, overriding their normal reaction to an aged environment. While this is nowhere as good a class of approach as repairing the underlying damage of aging, some of these types of therapy may turn out to produce large enough benefits to be worth the effort.


Neurogenesis occurs in the subgranular zone of the dentate gyrus (DG) in the hippocampus and the subventricular zone (SVZ) of the lateral ventricle in the adult mammalian brain. Adult hippocampal neurogenesis arises from neural stem cells (NSCs) within the DG. NSCs give rise to intermediate progenitor cells, which divide generating immature neurons that subsequently integrate into the local neural network as granule cells. Accumulating evidence suggests that adult-born neurons may play distinct physiological roles in hippocampus-dependent functions such as memory encoding and mood regulation. Age induces a decline in adult NSC activity and neuronal plasticity, which could partially explain some age-related cognitive deficit symptoms. Neuronal loss or dysfunction also contributes to the onset of age-related neurodegenerative pathologies.

Increasing evidence reveals that NSC activity is regulated by intrinsic and extrinsic factors. Among the latter, it has been recently shown that neuronal activity controls NSC quiescence and subsequently neurogenesis in the hippocampus. The molecular mechanism by which neuronal activity contributes to the regulation of NSCs, and whether this decreases with aging, remains unknown.

p38 mitogen-activated protein kinase (p38MAPK) is an important sensor of intrinsic and extrinsic stresses and consequently controls key processes of mammalian cell homeostasis such as self-renewal, differentiation, proliferation, and death. In the brain, p38MAPK signalling is activated during neurodegenerative diseases and in response to brain injury. Its genetic or pharmacological inhibition ameliorates symptoms of neurodegenerative diseases and protects against ischemia. The p38MAPK family comprises four members, with p38α and p38β being expressed at high levels in the brain. p38α has been involved in inflammation and environmental stresses, and there is evidence implicating p38α in neuronal function and cognitive activity with contradictory results.

Using mice, we demonstrate that genetic deletion of p38α in neurons suffices to reduce age-associated elevation of p38MAPK activity, neuronal loss and cognitive decline. Moreover, aged mice with genetic deletion of p38α present elevated numbers of NSCs in the hippocampus and the subventricular zone. These results reveal novel roles for neuronal p38MAPK in age-associated NSC exhaustion and cognitive decline.

Mitochondrial Mutator Mice May be a Poor Model

https://www.fightaging.org/archives/2019/10/mitochondrial-mutator-mice-may-be-a-poor-model/

Mitochondrial dysfunction and mitochondrial DNA damage are significant features of aging. One of the tools used to investigate the role of mitochondria in aging is the lineage of mitochondrial mutator mice. These mice accumulate mutations in mitochondrial DNA quite rapidly, and exhibit accelerated aging. Setting aside the discussion of what exactly qualifies as accelerated aging, researchers here present evidence to suggest that the mitochondrial mutation is not the cause of accelerated aging in this model. Instead, this particular approach to accelerating mitochondrial DNA damage leads in addition to accelerated nuclear DNA damage. This is consistent with the many other forms of accelerated aging that are caused by breakage of DNA repair mechanisms, and thus faster accumulation of unrepaired mutation in nuclear DNA.

The conclusion here is that mitochondrial mutator mice are a poor model, possibly just this model, possibly the entire class of such models as they stand, not that mitochondria are less relevant to aging. There is far and away too much evidence to dismiss mitochondrial damage and dysfunction as a cause of degenerative aging. If anything, this brings the mutator mice in line with other mouse lineages with high levels of mitochondrial mutation, as those do not display accelerated aging – their mechanisms of breakage are presumably not significantly impacting nuclear DNA mutation rates.


Mitochondria are small powerhouse organelles that have their own DNA, the mitochondrial DNA (mtDNA). For almost half a century, mitochondrial DNA mutations and oxidative stress have been asserted as major contributors to aging, as postulated in the mitochondrial theory of aging published in the 1970s. The theory has been tested on the mtDNA Mutator mice that have an inactive DNA repair mechanism. These mice accumulate mtDNA mutations and present with accelerated aging, which has led scientists to believe that mtDNA mutagenesis drives aging. However, despite rigorous studies by several groups, no one has been able to show that the Mutator mice would present elevated oxidative stress.

The prematurely-ageing Mutator mice harbour a defective polymerase-gamma enzyme and present with pronounced mtDNA mutagenesis. Despite the existence of other mouse models with equivalent mtDNA mutagenic propensity, the Mutator mouse model is the only one manifesting accelerated aging. Furthermore, progeria is not a clinical feature of mitochondrial disease patients, not even in those with the most severe mtDNA mutagenic profiles. Rather, the clinical picture of the mtDNA Mutator mice is remarkably similar to that of other mouse progeria models and human progeric syndromes with nuclear genome instability, with the most prominent defects in proliferating cells, and especially in stem cells and progenitor cells important for tissue regeneration.

The new study shows that in addition to the mtDNA maintenance defects, the Mutator mice also manifest nuclear DNA defects, including replication fork stalling, increased DNA-breaks and activation of DNA damage response pathways. So, how can a primary mitochondrial DNA maintenance defect affect the maintenance of nuclear genome? Nucleotides are the building blocks of DNA, and proper cellular nucleotide levels are critical for genome maintenance. Moreover, the cytoplasmic and mitochondrial nucleotide pools are interconnected. The researchers show that in the Mutator mice, the total cellular nucleotide levels are decreased, while the mitochondrial nucleotide pools are increased, suggesting preferential usage of nucleotides in the mitochondria. Indeed, the replication of mtDNA is drastically accelerated in the cells of the Mutator mice.

An Interview with Amutha Boominathan of the SENS Research Foundation

https://www.fightaging.org/archives/2019/10/an-interview-with-amutha-boominathan-of-the-sens-research-foundation/

Amutha Boominathan leads the mitochondrial research program at the SENS Research Foundation, focused on achieving allotopic expression of mitochondrial genes. This is the process of placing mitochondrial genes into the nuclear genome, suitably altered so that the proteins produced are transported back to mitochondria where they are needed. Every cell contains a herd of hundreds of mitochondria, the descendants of ancient symbiotic bacteria that contain a remnant circular genome. Mitochondria are responsible for packaging chemical energy store molecules, but are also deeply integrated into many other cellular processes.

Thirteen mitochondrial genes remain in the mitochondrial DNA, the source of proteins vital to the correct operation of these organelles, but far more vulnerable to damage and mutation than nuclear DNA. That damage and mutation is one of the root causes of aging, leading to dysfunctional cells that pump harmful oxidative molecules into the surrounding tissue. Adding backup genes to the cell nucleus should work around this issue by allowing mitochondria with damaged DNA to continue functioning, as they will still receive the necessary proteins.


Your research group started developing an improved method for allotopic expression of mitochondrial DNA in 2015 that has already shown very promising results?

The major hurdle that we have overcome is, at least, showing protein products for all the 13 genes. We made some fundamental changes to all 13 genes with a uniform approach, but that approach may not work equally well for all of them. We may have to engineer each one of them for specific properties. So, all of these 13 genes differ with respect to their length, their hydrophobicity, and the complexes that they target. The main hurdle is actually the hydrophobicity factor. These 13 proteins are normally synthesized within the mitochondrial matrix, and they are inserted into their complexes. But, in allotopic expression, they are synthesized in the cytosol and have to traverse two membranes and then go to the right location. We will have to engineer them one after the other or modify them in such a way that it recognizes the right pathway. So, like I said, we are causing global changes to all 13 genes, and we will cause specific changes to each one of them to make it functional as a whole. The first step is to at least see a product, and that’s what we’ve overcome now.

What have been the criteria for selecting mitochondrial DNA genes to work on for allotopic expression?

One of the other hurdles is proving that your technology actually works, and for that, you need model systems. The reason we were able to show that ATP8 really works is because we were able to get a patient cell line with a severe mutation that’s null for the ATP8 protein. Usually, in humans, mutations to mitochondrial genes manifest in various levels, but it is unusual that the protein is completely absent in the patient. It’s a rare event. But mitochondrial DNA exists in heteroplasmy. There are wild type and mutant levels, both present continuously, and it’s the tipping factor that causes a disease phenotype to ensue. The one reason we were able to really convincingly show ATP8 works is because we were able to get the null cell line and show that the exogenous protein goes into the right location and regains many of the functions that were absent before. Basically, you have the cell line available, which is really rare. So, let’s make use of it.

What do you think will be a realistic timeframe for therapies targeting mitochondrial DNA mutations to reach humans?

They are actually already doing that but with the recoded version. That means we already have a precedent. All we have to show is that our version of it is better and that ours has a better immune profile. That’s also why we want to do it in animal models, so we can actually show how it’s better. I don’t know about the timeframe; that’s a very difficult question. If the animal studies go well, I want to say five years. Not five years before it reaches people, but five years to establish enough proof of principle that we can start to develop this for people.

In your view, what does aging research need most right now to ensure it can make the most significant leaps that the field is capable of in the coming 10 years?

I think you need good biomarkers. That’s lacking in the field. Everybody wants to have a quick fix. They have all these different areas that they think are very important to aging, but I don’t think that’s the way it is. I think it’s more like a general breakdown of everything with time. So you need better markers, and maybe even a better mindset where it’s okay to be healthy in old age. People shouldn’t be resigned to the fact that they will age with time and that they are going to die. Maybe a little more public education is needed to accept that it’s okay to want and to have a healthy lifespan.

An Interview with Justin Rebo of BioAge

https://www.fightaging.org/archives/2019/10/an-interview-with-justin-rebo-of-bioage/

BioAge is one of a growing number of companies using machine learning methods to reduce cost and speed up discovery of drug targets, development of small molecule drugs, or peptides, or other aspects of traditional medical development than have been painfully costly, inefficient, and slow. Faster, cheaper processes in medical development are a benefit to humanity, and right now the novelty of this sort of work gives it a high profile in the entrepreneurial and investment communities. Faster and cheaper isn’t a substitute for choosing the right strategy for the development of therapies to treat aging, however.

After all, every therapy for aging prior to the development of senolytics to clear senescent cells was fairly marginal in its benefits. Many of the therapies presently under development in the longevity industry alongside the targeted destruction of senescent cells will also be marginal, because, unlike senolytics, they fail to meaningfully reverse a cause of aging. Producing marginal therapies at an accelerated rate is not a success story. Better infrastructure will only efficiently help the end goal of greatly extended healthy life span when coupled to a program of research and development that aims to repair the molecular damage that lies at the root of aging.


I was wondering if you could briefly explain how BioAge verifies whether the aging targets they identify are valid?

BioAge begins with human data. We find human cohorts that have banked blood samples from decades ago, coupled with electronic health records that have followed those people ever since, in some cases, until their deaths. We send these blood samples for deep omics profiling: proteomics, metabolomics, transcriptomics, stuff like that. From that, we can find what’s in the blood, for instance, the transcription profiles of the blood cells and soluble protein metabolites, which is correlated with age-related diseases and mortality. That’s only part of the picture, of course, because that doesn’t tell you what’s causal, it only tells you what’s correlational. So, from there, we adopt a systems biology approach where we connect the results to whatever datasets we can find out in the world or among those we generate ourselves, which gives us a few extra clues. However, ultimately, the only way we can really verify if a target is valid is by testing it experimentally, and so that’s what we do. After we pull everything together data-wise, that only gives us so much. We really need to test these targets in animal models as well as cell models, but we prefer to test in vivo.

Since research budgets are limited, what is your view on how these budgets should be allocated across these differing priorities, i.e. should the discovery of biomarkers for more diseases or the development of interventions take precedence if we need to choose, and why?

That’s how BioAge started: the whole point was to generate biomarkers. At the same time, these so-called biomarkers are often themselves druggable targets. Part of the evolution of BioAge as a company is that first we find these biomarkers, and then we turn them into drugs. In terms of how society should allocate resources (biomarker research versus the development of interventions), we personally don’t have to consider that as much, seeing as we’re doing both in-house. I can’t really say what anyone else should do, but I think we found something that works for us.

Aubrey de Grey’s idea is that if we develop a therapy for one subtype of causative damage of aging, it will be much easier to extend that therapy to similar types of damage. Since BioAge is working on using computational approaches to find the molecular pathways that drive aging, I was wondering if you are using a similar type of clustering approach to facilitate faster intervention development?

To some extent, because I love Aubrey’s integrated approach. For me, personally, his ‘seven deadly things’ talk was kind of my introduction into the field back in 2004/2005. But BioAge, at least initially, takes an opposite approach in the sense that we don’t cluster things. We look for mortality as our first differentiating factor. Any target that we look at as something that we might want to pursue must be associated with mortality, and mortality is really as broad as it gets. That being said, once we’ve screened for mortality, we then examine what specific disease indications would make the most sense. I can’t really get into detail about what those are. But I like the way we look broadly at the data first, in a kind of “hypothesis-free” sense, with an open mind, letting the data speak for itself.

The Upheaval in Alzheimer’s Research and Clinical Development

https://www.fightaging.org/archives/2019/10/the-upheaval-in-alzheimers-research-and-clinical-development/

It seems that the tipping point has been reached in the Alzheimer’s research and development community, in the sense that it is becoming more widely accepted that new approaches are needed. The failure to produce significant benefits to patients via clearance of amyloid from the brain by immunotherapy has spurred a great deal of theorizing, and several new and promising lines of work. For example, working on restoring age-related declines in drainage of cerebrospinal fluid might remove all metabolic waste from the brain. Alternatively, a focus on neuroinflammation and the role of dysfunctional microglia is suggested, particularly by studies of senolytics showing benefits in mouse models resulting from removal of senescent microglia. The monolithic focus on amyloid is giving way to a period of greater experimentation and diversity in clinical development, and this can only be a good thing when it comes to making progress towards effective treatments for Alzheimer’s disease.


In the last five years, as several large clinical trials testing drugs for Alzheimer’s disease failed, the field came to a stark conclusion: These approaches did nothing to slow down – let alone reverse – the course of the disease once patients already exhibited symptoms of early dementia. The failed trials, along with the dawning realization that the disease unfolds over decades, have put the entire field on a reset-to develop and test interventions that can be used much earlier, to discover new targets beyond misfolded amyloid and tau proteins, and to fund large, interdisciplinary, big data collaborations.

Aging is by far the biggest risk factor for developing Alzheimer’s – if everyone lived to be 85, one in two people would develop dementia. The lion’s share of Alzheimer’s research and drug discovery to date has focused on misfolded amyloid and tau proteins, which aggregate to form plaques (amyloid) and tangles (tau) in the brain. But the body’s attempt to clear the sticky proteins might also be contributing to or causing the neurodegeneration. Drug trials have almost exclusively sought to use antibodies targeted toward these two proteins to try to attack and clear the misfolded forms or mop up soluble forms, or to inhibit enzymes responsible for generating the miscreant peptides.

New areas being explored include the vascular system, epigenetics, neuroprotection, synaptic health, immunity and inflammation, and metabolic dysfunction, among others. Neuroinflammation and proteostasis, or the management of proteins within cells, are trending areas of research. Another booming area of Alzheimer’s research is the development of biomarkers and diagnostic tests to monitor disease presence and progression. Radioactive positron emission tomography (PET) tracers enable physicians to image and measure amyloid and tau proteins in the brains of living patients. Other biomarkers can be measured precisely from collecting cerebral spinal fluid. However, both types of tests are invasive, and PET scans are expensive. “We need a blood test like the one we have for cholesterol that can be done in any doctor’s office quickly and inexpensively.”

Investigating the Superior DNA Defenses of Tardigrades

https://www.fightaging.org/archives/2019/10/investigating-the-superior-dna-defenses-of-tardigrades/

Tardigrades are extremely resilient to radiation induced DNA damage, and here researchers delve into some of the mechanisms involved. Mining other species for potential improvements to our own biochemistry, or the basis for therapies, is an expanding line of work in the life science community. Possible ways to improve mammalian defenses against damage to nuclear DNA are of interest for a range of reasons, not least of which is that it is the present consensus that stochastic mutation to nuclear DNA contributes to both cancer risk and aging itself, as mutations in stem cells or progenitor cells can spread throughout tissues via clonal expansion.


Tardigrades, which are also known as water bears or moss piglets, are small invertebrate animals that are found in marine, freshwater, and terrestrial habitats throughout the Earth. Terrestrial tardigrades require a thin film of water to remain active. In the absence of water, they undergo anhydrobiosis into a dormant dehydrated state from which they can be rehydrated to an active form. In the anhydrobiotic state, tardigrades are resistant to extreme conditions of heat, cold, vacuum, pressure, radiation, and chemical treatments. Remarkably, they have been found to survive exposure to the vacuum and radiation of outer space.

The tardigrade Ramazzottius varieornatus contains a unique nuclear protein termed Dsup, for damage suppressor, which can increase the resistance of human cells to DNA damage under conditions, such as ionizing radiation or hydrogen peroxide treatment, that generate hydroxyl radicals. Here we find that R. varieornatus Dsup is a nucleosome-binding protein that protects chromatin from hydroxyl radicals. Moreover, a Dsup ortholog from the tardigrade Hypsibius exemplaris similarly binds to nucleosomes and protects DNA from hydroxyl radicals.

Strikingly, a conserved region in Dsup proteins exhibits sequence similarity to the nucleosome-binding domain of vertebrate HMGN proteins and is functionally important for nucleosome binding and hydroxyl radical protection. These findings suggest that Dsup promotes the survival of tardigrades under diverse conditions by a direct mechanism that involves binding to nucleosomes and protecting chromosomal DNA from hydroxyl radicals.

Have a look at Nitric Oxide and Cardio health and wellness.

Read More

Can Wasabi Break Your Heart?

Great Vitamin supplements needed for Cardiovascular Health


Searching for state-of-the-art authorised quality products?  Read about  these beneficial Endorsed Supplements.

Wasabi, the popular Japanese condiment served alongside sushi, has an intense, spicy heat that can easily make your eyes water if you eat too much at once. So, imagine the surprise one woman felt when she consumed an entire spoonful at once, after confusing it with avocado.

The woman, a 60-year-old living in Israel, experienced sudden pressure in her chest, which eventually subsided, but when she was still feeling unwell the next day, she went to the emergency room.1 In a case report detailed in BMJ Case Reports, researchers explain that the woman arrived at the emergency department with chest pain,2 where doctors thought she might be having a heart attack.

However, further testing revealed that her heart was misshaped, making it unable to pump blood properly. This is characteristic of takotsubo cardiomyopathy, a condition named for a Japanese octopus fishing pot — a takotsubo — which the heart resembles in its misshapen form.3

Another name for the condition is stress-induced cardiomyopathy or broken heart syndrome, because it often occurs in response to intense physical or emotional stress, such as the loss of a loved one.

Wasabi Leads to Broken Heart Syndrome

The BMJ case report is, to the researchers’ knowledge, the first report of broken heart syndrome triggered by wasabi. Eating a large amount of this spice could easily lead to intense physical symptoms, as even a small amount can cause a painful sensation in your sinuses and burning in your mouth.

The reason wasabi (Wasabia japonica), a member of the Brassicaceae family, commonly called the mustard family, is so hot is due to a defense mechanism of the plant — pests stay away since it’s so unpleasant when consumed. However, most “wasabi” is not actually the Japanese root of the same name but actually a mixture of horseradish, hot mustard and green food coloring.

Still, the shock of consuming so much of this spicy condiment could, indeed, “break” your heart, as occurred in the woman’s case. “Takotsubo cardiomyopathy is a left ventricular dysfunction that typically occurs after sudden intense emotional or physical stress and mimics myocardial infarction [heart attack],” the researchers explained.4

Stressors that may lead to broken heart syndrome include not only the loss of a loved one but also experiencing a natural disaster, an accident or an attack, among others. Serious illness, such as intracranial hemorrhage and sepsis, as well as pregnancy and sexual intercourse have also been known to trigger this syndrome.5 Other stressors associated with takotsubo cardiomyopathy include:6

Loss of a pet

Severe pain

Domestic violence

Asthma attack

Receiving bad news

Fierce argument

Financial loss

Intense fear

Public speaking

A sudden surprise, such as a surprise party

Broken heart syndrome is much more common in women than men, with 90% of cases occurring among women aged 58 to 75 years, although it can even occur in children.7 Overall, it’s suggested that about 2% of people who have symptoms of acute coronary syndrome actually have takotsubo cardiomyopathy, although this increases to 10% if only women are considered.8

Death of a Pet, Zumba Linked to Broken Heart Syndrome

Any type of extreme physical or emotional stress could theoretically stress your heart to the point that it “breaks.” Aside from consuming a spoonful of wasabi, this could also occur due to an intense workout, such as Zumba.

In a case report of a 38-year-old woman — younger than the typical age for this condition — researchers explained that the woman went to the emergency room due to chest pain that started after an intense two-hour Zumba workout.9 She had no other stressful events that would have been likely triggers. The researchers explained:10

“Our patient did not have one clear trigger for her overt Takotsubo cardiomyopathy other than the Zumba activity. Zumba is considered an activity with excessive sympathetic stimulation leading to catecholamine-induced microvascular spasm or through to direct myocardial toxicity, which is postulated to be behind the pathophysiology of Takotsubo cardiomyopathy.”

The New England Journal of Medicine also presented a case report of a 61-year-old woman who went to the emergency room with chest pain and was later diagnosed with takotsubo cardiomyopathy.11 She indicated that she’d experienced multiple stressors, including the death of her dog.12 When her pet, a 9-year-old Yorkshire terrier, died, “’I was close to inconsolable,’ she told The Washington Post.”13

Release of Stress Hormones and the Brain May Be to Blame

As for why an intensely stressful experience can cause your heart to stop working properly, it likely has to do with the release of stress hormones. This can occur from both positive and negative stressors. According to the Cleveland Clinic:14

A person’s reaction to such events causes a release of stress hormones (catecholamines) that temporarily reduce the effectiveness of the heart’s pumping action, or cause it to contract too forcefully or wildly instead of in a steady pattern … The impact of stress hormones ‘stuns’ the cells of the heart, causing them to malfunction.”

That being said, having a history of neurological problems, such as seizure disorders and/or a history of mental health problems is thought to raise your risk.15

It’s also recently been suggested that the brain may play a role in takotsubo cardiomyopathy and in people with the condition, regions of the brain linked to emotional processing and control of heartbeat, breathing and digestion may not communicate the way they do in people without broken heart syndrome.16,17

Study author Christian Templin, professor of cardiology at University Hospital Zurich, said in a news release:18

“For the first time, we have identified a correlation between alterations to the functional activity of specific brain regions and TTS [takotsubo cardiomyopathy], which strongly supports the idea that the brain is involved in the underlying mechanism of TTS.

Emotional and physical stress are strongly associated with TTS, and it has been hypothesized that the overstimulation of the autonomic nervous system may lead to TTS events.”

As mentioned, symptoms often mimic those of a heart attack and include:19

Sudden, severe chest pain (angina)

Shortness of breath

Irregular heartbeat (arrhythmia)

Fainting

Low blood pressure

Heart failure

Typically, patients with takotsubo cardiomyopathy are treated with medications to lower blood pressure and decrease fluid buildup. Symptoms usually resolve within a matter of days or weeks, with no permanent damage to the heart muscle remaining.

In most cases a typical heart attack occurs due to blockages in the coronary arteries that stop blood flow and cause heart cells to die, leading to irreversible damage. But people with broken heart syndrome often have normal arteries without significant blockages. The symptoms occur due to the emotional stress, so when the stress begins to die down, the heart is able to recover.

Most people who experience broken heart syndrome won’t experience it again, but it does recur in about 10% of cases.20 While most people recover fully, it can be fatal or lead to other complications. As noted in Clinical Autonomic Research:21

The syndrome is usually reversible; nevertheless, during the acute stage, a substantial number of patients develop severe complications such as arrhythmias, heart failure including pulmonary edema and cardiogenic shock, thromboembolism, cardiac arrest, and rupture.”

In Most Cases, Wasabi Is Good for You

Assuming you eat wasabi as most people do — in small quantities at a time — it can be quite good for you. There’s no reason to fear that it could cause extreme stress to your heart, as long as you don’t overdo it. Remember, in most cases, when you eat wasabi, you’re primarily consuming horseradish.

The heat and flavor come from allyl isothiocyanate (ITC), which is formed when the root is grated finely. The ITCs in horseradish and wasabi were found in clinical trials to reduce “colon, lung and stomach cancer cell activity by 28%, 17% and 44%, respectively.”22

Wasabi’s isothiocyanates may also help prevent platelet aggregation,23 which is the clumping together of red blood cells that may lead to blood clots that are risk factors for stroke and other cardiovascular diseases.

Wasabi also has antibacterial activity, including against E. coli O157:H7 and Staphylococcus aureus, two of the major causes of foodborne disease outbreaks.24 Other compounds in wasabi may help to fight inflammation as well. This includes 6-(Methylsulfinyl)hexyl isothiocyanate (6-MSITC), which has anti-inflammatory, antimicrobial, antiplatelet and anticancer effects.25

Because cultivating true wasabi plants is difficult, real wasabi is much harder to find (and more expensive) than wasabi imposters. Still, if you can’t find real wasabi, you can still reap many of the same benefits by eating wasabi made from horseradish — just seek out high-quality versions that do not contain artificial flavors or colors or additives such as genetically engineered corn and soy.

Can Broken Heart Syndrome Be Prevented?

Clearly, not eating a large amount of wasabi at one time is recommended not only to avoid broken heart syndrome, but also to avoid unnecessary discomfort. However, as far as preventing broken heart syndrome goes, there are no guarantees. Because this condition is linked to extreme physical and emotional stress, you can help to avoid it by managing your stress levels on a daily basis.

The Emotional Freedom Techniques (EFT) is one of the best options for doing so. Mindfulness-based stress reduction techniques like mindfulness meditation are also helpful, and applying Buteyko breathing, which involves breathing through your nose, not your mouth, also really helps to calm the mind and get into deep states of relaxation.

Sometimes extreme stress is unavoidable, but managing daily stress is one way to protect your overall health from its ill effects. In any case, if you experience chest pain after a stressful event — even something like eating wasabi — it’s a good idea to get medical help right away to rule out a heart attack or broken heart syndrome.

Study more about N . O . and Cardio health and wellness.

Read More

Is Displaced Nuclear DNA a Meaningful Cause of Chronic Inflammation in Aging?

Very best Supplements regarding Heart


Hunting for top quality recognised nutritional supplements?  Educate yourself about  these quality Recognized Supplements.

Sterile inflammation arises without external cause, such as infection or injury, and chronic sterile inflammation is a characteristic of aging. Inflammatory signaling becomes constant and pronounced in tissues, and the immune system is constantly roused to action. Processes, such as regeneration from injury, that depend upon a clear cycle of inflammation that starts, progresses, and resolves are significantly disrupted. It is no exaggeration to say that the downstream consequences of chronic inflammation accelerate the progression of all of the common age-related conditions. It is of great importance in atherosclerosis and neurodegenerative conditions, for example. Like raised blood pressure, chronic inflammation is one of the more important mechanisms acting to convert the low-level molecular damage at the root of aging into the various proximate causes of age-related disease and mortality.

Thus the research community is greatly interested in understanding how and why sterile inflammation arises in later life. Cellular senescence is one sizable area of investigation, as senescent cells accumulate with age, and secrete inflammatory signals. Additionally, visceral fat tissue acts to increase the pace at which senescent cells arise, but also contributes to inflammation via other mechanisms. In the short open access commentary here, the authors discuss a potential mechanism whereby cells in aged tissues start to eject DNA fragments from the cell nucleus, and this can cause reactions that lead to inflammatory signaling. This is probably important in cellular senescence, but may also operate in other cells.

Damaged DNA marching out of aging nucleus


Subclinical but heightened inflammation in the absence of infection is a key feature of aging, and includes senescent cells that secrete cytokines. Yet, what are the intrinsic processes that initiate ‘inflammaging‘, and possibly other forms of sterile inflammation, like autoimmunity? Self-DNA has long been suspected as trigger and target of autoimmunity, as anti-nuclear antibodies, anti-dsDNA (double-stranded DNA) antibodies and plasma DNA are observed in autoimmune patients of lupus and rheumatoid arthritis.

In studying the initiating events leading to autoimmune arthritis in mice deficient for the lysosomal nuclease DNASE2A, we revealed an unexpected ‘hidden’ source of this inflammatory DNA – the cell’s own nucleus. In healthy cells, damaged and irreparable nuclear DNA fragments are trafficked to the cytosol, enclosed by autophagosomes, and delivered to the lysosomes for degradation by DNASE2A. Lacking DNASE2A, extranuclear DNA accumulates in cells and induces inflammation via innate DNA sensing. Cytosolic DNA sensing is activated when dsDNA binds the DNA sensor enzyme cGAS (cyclic GMP-AMP synthase), converting GTP and ATP into the endogenous second messenger cGAMP, which in turns activates the adaptor protein STING (stimulator of interferon genes) and induces innate immune responses and inflammation. Nuclear DNA as a trigger of immunity could help explain a range of inflammatory conditions.

As cells age, damaged DNA accumulates over time. As an interesting aside, anti-dsDNA antibodies are also found at higher levels in older adults. Could damaged DNA march out of the nucleus of an old cell to set off inflammaging? Indeed, in replicative and oncogene-induced senescent cells, damaged nuclear DNA is exported. Clearing DNA is perhaps the most effective way to eliminate its inflammatory danger. As the only known acidic DNA endonuclease, DNASE2A preferentially degrades dsDNA. It resides with the lysosome, where intracellular and extracellular DNA cargoes converge for degradative digestion. In mice, Dnase2a-deficient cells exhibits the typical senescent phenotype of enlarged cells, slow cell growth, and increased expression of aging markers (senescence-associated β-gal activity, p16 and HP1β expression). Indeed, ectopic expression of DNASE2A substantially reduces cytosolic DNA abundance, innate immune activation and cellular aging phenotype in old cells, thus confirming the protective role of enzymatic DNA degradation in limiting inflammation.

Growing evidence now supports a unifying theory that damaged or irreparable DNA leaves the nucleus to drive aging-related inflammation via innate DNA sensing. Where DNA damage is increased (aging), DNA repair inhibited (ataxia), or nuclear barrier compromised (progeria), DNA load may be not reduced promptly or sufficiently, leading to inflammation. So how far can this DNA theory help to understand the cellular immune mechanisms underlying aging? Each nucleus holds a massive reservoir of endogenous DNA that can trigger local and systemic immunity if there are internal abnormalities such as DNA damage. How nuclear DNA export, trafficking, sensing, and degradation is coordinated to maintain cellular homeostasis is largely unknown. DNA danger coming from within generates exciting questions that probe into the basic life cycle of broken DNA fragments, and suggest ways of treating self-DNA-mediated sterile inflammation (autoimmunity, cancer, neurodegeneration, and chemotherapy) by regulating the abundance of mis-localized DNA.

Read additional info on Nitric Oxide Supplement and Heart health and fitness.

Read More

Investigating the Superior DNA Defenses of Tardigrades

Preferred Dietary supplements in support of Heart


Seeking unsurpassed approved products?  Educate yourself about  these important Recognized Vitamins.

Tardigrades are extremely resilient to radiation induced DNA damage, and here researchers delve into some of the mechanisms involved. Mining other species for potential improvements to our own biochemistry, or the basis for therapies, is an expanding line of work in the life science community. Possible ways to improve mammalian defenses against damage to nuclear DNA are of interest for a range of reasons, not least of which is that it is the present consensus that stochastic mutation to nuclear DNA contributes to both cancer risk and aging itself, as mutations in stem cells or progenitor cells can spread throughout tissues via clonal expansion.


Tardigrades, which are also known as water bears or moss piglets, are small invertebrate animals that are found in marine, freshwater, and terrestrial habitats throughout the Earth. Terrestrial tardigrades require a thin film of water to remain active. In the absence of water, they undergo anhydrobiosis into a dormant dehydrated state from which they can be rehydrated to an active form. In the anhydrobiotic state, tardigrades are resistant to extreme conditions of heat, cold, vacuum, pressure, radiation, and chemical treatments. Remarkably, they have been found to survive exposure to the vacuum and radiation of outer space.

The tardigrade Ramazzottius varieornatus contains a unique nuclear protein termed Dsup, for damage suppressor, which can increase the resistance of human cells to DNA damage under conditions, such as ionizing radiation or hydrogen peroxide treatment, that generate hydroxyl radicals. Here we find that R. varieornatus Dsup is a nucleosome-binding protein that protects chromatin from hydroxyl radicals. Moreover, a Dsup ortholog from the tardigrade Hypsibius exemplaris similarly binds to nucleosomes and protects DNA from hydroxyl radicals.

Strikingly, a conserved region in Dsup proteins exhibits sequence similarity to the nucleosome-binding domain of vertebrate HMGN proteins and is functionally important for nucleosome binding and hydroxyl radical protection. These findings suggest that Dsup promotes the survival of tardigrades under diverse conditions by a direct mechanism that involves binding to nucleosomes and protecting chromosomal DNA from hydroxyl radicals.

Link: https://doi.org/10.7554/eLife.47682

Read more about N . O . and Heart health.

Read More

The Upheaval in Alzheimer's Research and Clinical Development

Optimum Nutritional supplements for Cardiovascular Health


Hunting for superior endorsed nutritional supplements?  Read and learn about  these quality Medically Endorsed Vitamins.

It seems that the tipping point has been reached in the Alzheimer’s research and development community, in the sense that it is becoming more widely accepted that new approaches are needed. The failure to produce significant benefits to patients via clearance of amyloid from the brain by immunotherapy has spurred a great deal of theorizing, and several new and promising lines of work. For example, working on restoring age-related declines in drainage of cerebrospinal fluid might remove all metabolic waste from the brain. Alternatively, a focus on neuroinflammation and the role of dysfunctional microglia is suggested, particularly by studies of senolytics showing benefits in mouse models resulting from removal of senescent microglia. The monolithic focus on amyloid is giving way to a period of greater experimentation and diversity in clinical development, and this can only be a good thing when it comes to making progress towards effective treatments for Alzheimer’s disease.


In the last five years, as several large clinical trials testing drugs for Alzheimer’s disease failed, the field came to a stark conclusion: These approaches did nothing to slow down – let alone reverse – the course of the disease once patients already exhibited symptoms of early dementia. The failed trials, along with the dawning realization that the disease unfolds over decades, have put the entire field on a reset-to develop and test interventions that can be used much earlier, to discover new targets beyond misfolded amyloid and tau proteins, and to fund large, interdisciplinary, big data collaborations.

Aging is by far the biggest risk factor for developing Alzheimer’s – if everyone lived to be 85, one in two people would develop dementia. The lion’s share of Alzheimer’s research and drug discovery to date has focused on misfolded amyloid and tau proteins, which aggregate to form plaques (amyloid) and tangles (tau) in the brain. But the body’s attempt to clear the sticky proteins might also be contributing to or causing the neurodegeneration. Drug trials have almost exclusively sought to use antibodies targeted toward these two proteins to try to attack and clear the misfolded forms or mop up soluble forms, or to inhibit enzymes responsible for generating the miscreant peptides.

New areas being explored include the vascular system, epigenetics, neuroprotection, synaptic health, immunity and inflammation, and metabolic dysfunction, among others. Neuroinflammation and proteostasis, or the management of proteins within cells, are trending areas of research. Another booming area of Alzheimer’s research is the development of biomarkers and diagnostic tests to monitor disease presence and progression. Radioactive positron emission tomography (PET) tracers enable physicians to image and measure amyloid and tau proteins in the brains of living patients. Other biomarkers can be measured precisely from collecting cerebral spinal fluid. However, both types of tests are invasive, and PET scans are expensive. “We need a blood test like the one we have for cholesterol that can be done in any doctor’s office quickly and inexpensively.”

Link: https://www.sciencemag.org/features/2019/10/alzheimers-research-reset

Discover more about Nitric Oxide Supplements and Heart fitness.

Read More

Air Pollution Now Strongly Linked to Mental Illness

The best Supplements designed for Nitric Oxide Health


Browsing for unsurpassed authorised quality health supplements?  Discover about  these special Recognised Vitamins.

Worldwide, 93% of children live in areas with air pollution at levels above World Health Organization (WHO) guidelines.1 Further, more than 1 in 4 deaths among children under 5 years is related to environmental risks, including air pollution.

When most people think about health risks linked to polluted air, respiratory issues come to mind and, indeed, in 2016 ambient (outside) and household air pollution contributed to respiratory tract infections that led to 543,000 deaths in children under 5.2 However, air pollution takes a toll on the whole body, contributing not only to physical risks but also mental health problems.

A set of studies by researchers at Cincinnati Children’s Hospital, in collaboration with researchers at the University of Cincinnati, has highlighted the risks to children, in particular, who may see their mental health suffer as a result of polluted air.

Three Studies Link Air Pollution to Mental Health Risks

In the first study, published in Environmental Health Perspectives, researchers looked at the association between emergency room visits and exposure to fine particulate matter (PM 2.5), which refers to dust, dirt, soot and smoke particles smaller than 2.5 micrometers in diameter.3

The WHO report revealed that in low- and middle-income countries, 98% of children under 5 years are exposed to fine particulate matter at levels higher than the WHO air quality guidelines.

The Environmental Health Perspectives study revealed that short-term exposure to air pollution was linked to increased utilization of the Cincinnati Children’s emergency department for psychiatric issues, particularly for adjustment disorder and suicidality.

Further, mental health of children living in high-poverty neighborhoods was most affected by air pollution. Lead study author Cole Brokamp, Ph.D., with Cincinnati Children’s Hospital, said in a news release:4

“This study is the first to show an association between daily outdoor air pollution levels and increased symptoms of psychiatric disorders, like anxiety and suicidality, in children. More research is needed to confirm these findings, but it could lead to new prevention strategies for children experiencing symptoms related to a psychiatric disorder.”

Air Pollution May Cause Brain Inflammation, Anxiety Symptoms

The second study, published in the August 2019 issue of Environmental Research, looked into exposure to traffic-related air pollution (TRAP) on brain metabolism and symptoms of generalized anxiety in 12-year-olds.5 Recent exposure to TRAP was associated with generalized anxiety symptoms and increased myo-inositol, a marker of inflammation in the brain.

“This is the first study of children to utilize neuroimaging to link TRAP exposure, metabolite dysregulation in the brain, and generalized anxiety symptoms among otherwise healthy children,” the researchers concluded. “TRAP may elicit atypical excitatory neurotransmission and glial inflammatory responses leading to increased metabolite levels and subsequent anxiety symptoms.”6

The third study, also published in Environmental Research, found that early-life exposure to TRAP, as well as exposure during childhood, was significantly associated with depression and anxiety symptoms in 12-year-olds.7 A similar association between air pollution and mental health was previously reported among adults, but this study suggests the effects may also occur in children exposed to air pollution.

“Collectively, these studies contribute to the growing body of evidence that exposure to air pollution during early life and childhood may contribute to depression, anxiety, and other mental health problems in adolescence,” Patrick Ryan, Ph.D., a lead author of the Environmental Health Perspectives study, said in a news release. “More research is needed to replicate these findings and uncover underlying mechanisms for these associations.”8

Past research has also found that living in an area with higher levels of air pollution is associated with decreased cognitive function and sleep disturbances.9

“Evidence that exposure to air pollution affects brain structure was found by magnetic resonance imaging (MRI) of participants in the Framingham Offspring Study, indicating that higher exposure to PM2.5 is associated with a reduction in total brain volume,” according to a Royal College of Physicians report.10

Why Children Are Especially Vulnerable to Air Pollution

When children are exposed to pollutants, they’re even more vulnerable than adults, in part because their bodies (including their lungs and brains) are still developing, putting them at risk from inflammation and other health damage. They also have a longer life expectancy, giving more time for diseases to emerge.

According to WHO, a combination of “behavioral, environmental and physiological factors” makes children particularly susceptible to air pollution, adding:11

“[Children] breathe faster than adults, taking in more air and, with it, more pollutants. Children live closer to the ground, where some pollutants reach peak concentrations. They may spend much time outside, playing and engaging in physical activity in potentially polluted air.

Newborn and infant children, meanwhile, spend most of their time indoors, where they are more susceptible to household air pollution, as they are near their mothers while the latter cook with polluting fuels and devices … In the womb, they are vulnerable to their mothers’ exposure to pollutants. Exposure before conception can also impose latent risks on the fetus.”

Exposure to air pollution has also been linked to problems with fetal brain growth.12 The WHO report analyzed studies published within the past 10 years, and used input from dozens of experts, to reveal some of the top health risks air pollution poses to children. Among them:13

Adverse birth outcomes, including low birth weight, premature birth, stillbirth and infants born small for gestational age.

Infant mortality; as pollution levels increase, so does risk of infant mortality.

Neurodevelopment — Exposure to air pollution may lead to lower cognitive test outcomes, negatively affect children’s mental and motor development and may influence the development of autism and attention deficit hyperactivity disorder.

Childhood obesity

Lung function — Prenatal exposure to air pollution is associated with impaired lung development and lung function in childhood.

Acute lower respiratory infection, including pneumonia

Asthma — Exposure to ambient air pollution increases the risk of asthma and exacerbates symptoms of childhood asthma.

Ear infection

Childhood cancers, including retinoblastomas and leukemia

Health problems in adulthood — Evidence suggests that prenatal exposure to air pollution may increase the risk of chronic lung disease and cardiovascular disease later in life.

Air Pollution Interferes With Sleep

Research presented at the American Thoracic Society (ATS) 2017 International Conference suggested poor air quality may also disrupt your sleep.14

People in the top quarter of NO2 exposure (nitrogen dioxide, which is traffic-related air pollution) were 60% more likely to have low sleep efficiency over a five-year period compared to those in the lowest quarter. Among those exposed to the highest levels of fine particle pollution, there was a 50% increased likelihood of low sleep efficiency.

The researchers suggested the effect could be related to air pollution’s effects on the “central nervous system and brain areas associated with breathing control and sleep.”15

Sleep, in turn, is intricately linked to mental health, so one way air pollution may contribute to mental health symptoms could be by disturbing sleep. Meanwhile, previous research suggests that children with mood disorders or negative emotional symptoms may be more vulnerable to the harms of air pollution exposure.16

In other words, among people with poorer mental health, air pollution may lead to greater physical risks, including higher heart rate and blood pressure, and lower lung function, compared to those with better mental health.17 Mental illness could therefore potentially determine a population at increased risk of adverse health effects from air pollution.

Agriculture Is a Major Source of Air Pollution

The majority of global airborne particulate pollution — 85% — comes from fuel combustion, with coal being the “world’s most polluting fossil fuel.”18 Even in the U.S., an estimated 200,000 premature deaths are caused by combustion emissions, including that from vehicles and power generation.19

However, research published in the journal Geophysical Research Letters demonstrated that in certain densely populated areas, emissions from farming far outweigh other sources of particulate matter air pollution.20 The study found that in Europe, the eastern U.S. and China, agriculture is a significant source of PM2.5.21 Further:22

“In the past 70 years, global ammonia emissions have more than doubled, from 23 Tg/yr to 60 Tg/yr. This increase is entirely attributed to NH3 [ammonia] emissions from agriculture, with N fertilizer use contributing 33% and livestock production 66%. The emissions from livestock production come from animal houses and storage systems, animal manure, and grazing.”

Ammonia is one of the byproducts of fertilizer and animal waste. When the ammonia in the atmosphere reaches industrial areas, it combines with pollution from diesel and petroleum combustion, creating microparticles. Concentrated animal feeding operation (CAFO) workers and neighboring residents alike report higher incidence of asthma, headaches, eye irritation and nausea.

Research published in the American Journal of Respiratory and Critical Care Medicine also revealed that markers of lung function were related to how far they lived from CAFOs.23

Protecting Yourself From Polluted Air

Air pollution poses a silent yet insidious threat to human health, one that can be difficult to get away from depending on where you live and work. WHO, in fact, reported that only 8% of people worldwide are breathing air that meets their standards.24

One important step is to fortify your body with anti-inflammatory vegetables and fats, which may help to protect you from some of the damage air pollution causes. Notable standouts include:25

  • Omega-3 fats — They’re anti-inflammatory, and in a study of 29 middle-aged people, taking an animal-based omega-3 fat supplement reduced some of the adverse effects to heart health and lipid levels, including triglycerides, that occurred with exposure to air pollution (olive oil did not have the same effect).26
  • Broccoli sprouts — Broccoli-sprout extract was shown to prevent the allergic nasal response that occurs upon exposure to particles in diesel exhaust, such that the researchers suggested broccoli or broccoli sprouts could have a protective effect on air pollution’s role in allergic disease and asthma.27 A broccoli-sprout beverage even enhanced the detoxification of some airborne pollutants among residents of a highly-polluted region of China.28
  • Vitamins C and E — Among children with asthma, antioxidant supplementation including vitamins C and E helped to buffer the impact of ozone exposure on their small airways.29
  • B vitamins A small-scale human trial found high doses of vitamins B6, B9 and B12 in combination completely offset damage caused by very fine particulate matter in air pollution. Four weeks of high-dose supplementation reduced genetic damage in 10 gene locations by 28% to 76%, protected mitochondrial DNA from the harmful effects of pollution, and even helped repair some of the genetic damage.30

Tending to the quality of your home’s indoor air is also important, since most people spend the majority of their time inside. In fact, not only do Americans spend about 90% of their time indoors, but some pollutants may be two to five times more concentrated indoors than out.31 One commonsense measure is to simply open your windows to let fresh air in.

Installing an attic fan can also help bring fresh air into your home while installing kitchen and bathroom fans that vent to the outside can help remove contaminants from these rooms. The following steps will further help to improve your indoor air quality:

Consider a heat recovery ventilator (HRV) — Since most newer homes are airtight and therefore more energy efficient, air exchange with outdoor air is challenging. Some builders are now installing HRV systems to help prevent condensation and mold growth and improve indoor air quality.32

If you can’t afford an HRV, open your windows and run the bathroom and kitchen exhaust fans to vent your indoor air to the outside. You don’t have to do this for more than 15 to 20 minutes each day and should do it summer and winter at times when the temperature outside is closest to your indoor temperature.

Service fuel-burning appliances — Poorly maintained natural gas heaters and stoves, furnaces, hot water heaters, space heaters, water softeners and other fuel-burning appliances may leak carbon monoxide and nitrogen dioxide.33

Keep indoor humidity below 50% — Mold grows in damp and humid environments. Use a dehumidifier and air conditioner to keep your humidity under 50%. Keep the units cleaned so they aren’t a source of pollution.

Don’t smoke indoors — Ask smokers to go outside. Secondhand smoke from cigarettes, pipes and cigars contains over 200 known carcinogenic chemicals, endangering your health.

Don’t use scented candles, room fresheners or hazardous cleaning supplies — Candles and air fresheners release dangerous volatile organic compounds (VOCs) into your home. Instead, remove all garbage from your home as often as necessary and keep soiled laundry away from the living areas. Clean with less hazardous supplies, such as white vinegar and baking soda, and add essential oils for a clean scent.34

Test for radon — Radon is a colorless, odorless gas linked to lung cancer. It can be trapped under your home during construction and may leak into your air system over time. Radon testing kits are a quick and cheap way to determine if you are at risk.

Clean air ducts and change filters — The air ducts from your forced air heating and air conditioning units may be a source of pollution in your home. If there is mold growth, a buildup of dust and debris or if the ducts have become home to vermin, it’s time to call a professional and have them cleaned. Change your furnace filters every three months or earlier if they appear to be dirty.

Study more about Nitric Oxide Supplement and Cardiovascular health and wellness.

Read More

Heart of the Matter Documentary

Superior Nutritional supplements designed for Nitric Oxide Health


Hunting for quality authorised quality products?  Read and learn about  these Recognised Vitamins.

Contrary to the saturated fat/cholesterol theory, the most significant risk factors for cardiovascular disease (CVD) are actually insulin resistance, Type 2 diabetes and the chronic inflammation associated with these conditions. The damage to interior layers of arteries that invites cholesterol-rich plaque buildup can also be induced by elevated blood sugar, smoking, stress and high blood pressure.

A two-part documentary called “Heart of the Matter,” which ran on the Australian Broadcasting Corporation show ABC Catalyst in 2014, does an excellent job of exposing the cholesterol/saturated fat myths behind the statin fad and the financial links which lurk underneath. In fact, the documentary was so thorough in debunking the myths behind the popularity of statins, that vested interests1 convinced ABC TV to rescind the series.

The credentials of the documentary’s producer, Maryanne Demasi, were impeccable: She has a Ph.D. in neurology, no conflicts of interest and a long history of investigative journalism. But the Australian Heart Foundation, the three largest statin makers (Pfizer, AstraZeneca and Merck Sharp & Dohme) and Medicines Australia, Australia’s drug lobby group, complained2 and all the documentaries were expunged from ABC TV. Luckily they remain online.

Saturated Fat Theory of Heart Disease Began With Ancel Keys

According to the “Heart of the Matter,” American physiologist Ancel Benjamin Keys can be credited with originating and cementing the saturated fat/cholesterol theory of heart disease (though perhaps we should say indicted instead of credited).3

In the 1950s, Keys produced research that showed perfect correlations between cardiovascular disease and the dietary consumption of fat in several prominent Western countries. But there was just one problem with the research. Keys “withheld the data from 16 other countries,” Demasi notes in the documentary.4

Keys was scientifically influential and got a board position at the American Medical Association, which caused wide medical acceptance of the theory that continues today. His research also shaped the ubiquitous USDA food pyramid of years past (now replaced by MyPlate), which emphasized heavy portions of breads, cereals, rice and pasta.5

While Keys’ research was adopted years before the invention of statins, other groups of financial beneficiaries already existed — the sugar and grain industries. Sugar soon became a popular stand-in in low-fat foods to improve taste. In fact the dangers of growing sugar consumption inspired British professor John Yudkin to write a 1972 book, “Pure White and Deadly.” Fat was also replaced with carbohydrates, a move that benefited the grain lobby.

Bad Dietary Advice Resulted From Keys’ Research

Few scientific studies have confirmed Ancel Keys’ broadly adopted but skewed research, and several have reached opposite conclusions, says “Heart of the Matter.” But the tenacity of his theory has resulted in bad dietary advice. Take the case of margarine.

One of the worst examples of switching from saturated fats to something believed to be less conducive to heart disease is the embrace of margarine, according to cardiologist Dr. Stephen Sinatra in the documentary. When you switch to margarine and other “double-bonded” transfats — also called polyunsaturated and omega 6 fats — you are putting your health at risk, he says.

Such fats, which are the basic ingredients in most processed and snack foods, are prone to become rancid, causing oxidation and free radical attacks in the human body. Those chemical reactions produce the inflammation that is the real cause of heart disease, Sinatra says, adding that the damage from omega 6 fats is best combated by consuming omega 3 fats found in salmon, flaxseeds and walnuts.

Beware of Other Unsafe Alternatives

In “Heart of the Matter,” David Sullivan, associate professor and lipid expert with Royal Prince Alfred Hospital in Sydney, Australia, cautions against replacing saturated fats with carbohydrates because it contributes to obesity and may even make people hungrier.6

Many marketers of processed and snack foods also add refined sugar and processed fructose to improve taste when they try to advertise themselves as “low-fat,” but these products are in fact the primary drivers of heart disease, as I have pointed out in numerous newsletters.

Any meal or snack high in carbohydrates like fructose and refined grains creates a quick rise in blood glucose and, subsequently, a rise in insulin to compensate for the rise.

The blood sugar rise not only increases the risk of heart disease, the insulin released from these foods makes it harder to lose weight because it encourages fat accumulation, especially abdominal fat. Of course, abdominal fat is one of the major contributors to metabolic syndrome which, in turn, contributes to heart disease.

Many Flaws Are Found in the Saturated Fat Theory

“Heart of the Matter” features several experts who dispute the saturated fat theory based on their own clinical experience. For example, Dr. Rita F. Redberg, a cardiologist who practices in the University of California San Francisco cardiology unit, says, “cholesterol is just a lab number” and only one factor in heart disease along with general lifestyle.

Sinatra says he believed the saturated fat theory, too, until he actually looked carefully at the X-rays of those with heart disease. The angiograms showed both high and low levels of plaque-filled arteries, and therefore were not predictive or helpful in deciphering the cause of heart disease. Cholesterol is only harmful when it’s oxidized, he says.

Dr. Ernest N. Curtis, a cardiology specialist, agrees that saturated fat is not the cause of heart disease and adds that human levels of cholesterol are “preset” and mostly do not come from diet. If cholesterol from food is reduced, the human body tends to compensate by replacing it to keep the same levels, the documentary’s experts agree.

Cholesterol also serves valuable functions in the human body, and elimination should not be a goal, says Dr. John Abramson of Harvard Medical School Public School of Health in “Heart of the Matter.” Rather, it is “the precursor to many of the hormones in our body,” he asserts. Cholesterol also protects cell membranes, digests food and manufactures vitamin D after exposure to the sun.

Problems With the LDL Hypothesis

At the heart of the theory that saturated fat/cholesterol causes heart disease (pun intended) is the high-density lipoprotein hypothesis which designates high-density lipoprotein (HDL) as the “good” cholesterol and low-density lipoprotein (LDL) as the “bad” cholesterol. But, says “Heart of the Matter,” the lipoproteins neither deposit nor remove cholesterol as the theory holds but, rather, simply “ferry” cholesterol in the body.

It is stress and damage on the artery wall that allows the inflammation and degradation that leads to heart disease, says Curtis. That’s why plaque is usually seen at arterial “branches,” where there is more pulsating pressure as arteries divide. Since veins escape the pressure of returning blood that arteries perform, plaque is not seen in them, he says — unless veins are recruited to serve as arteries through bypass operations. Clearly, such surgery is not a solution to the problem.

More Problems With the LDL Hypothesis

“Heart of the Matter” is not the only source of skepticism about the LDL hypothesis. Here is what Dr. Malcolm Kendrick, a Scottish general practitioner, writes on the theory and its implausibility.7

“For the LDL hypothesis to be correct, it requires that LDL can travel past the lining of the artery, the endothelial cells, and into the artery wall behind. This is considered the starting point for atherosclerotic plaques to form. The problem with this hypothesis is … the only way for LDL to enter any cell, is if the cell manufactures an LDL receptor — which locks onto, and then pulls the LDL molecule inside. There is no other passageway.

There are no gaps between endothelial cells. Endothelial cells are tightly bound to each other by strong protein bridges, known as ‘tight junctions.’ These tight junctions can prevent the passage of single ions — charged atoms — which makes it impossible for an LDL molecule to slip through, as it is many thousands of times bigger than an ion. This, too, is an inarguable fact.”

The Boom of Statins Rests on the Saturated Fat Theory

Needless to say, the boom in statins seen since 1996 — Lipitor was the best-selling drug in the world before its patent expired — has rested on the theory that saturated fat/cholesterol is the cause of CVD. Yet, expert after expert in “Heart of the Matter” not only say that studies show statins only lengthen a life by a few days, but they are shockingly ineffective for all but a few people, despite their hype and popularity.

Statins’ serious side effects have been downplayed by those who drank the saturated fat/cholesterol “Kool-Aid” theory, either because of professional hubris or because they are directly profiting from statins.8 Yet, the side effects of statins are serious and include an increased risk for diabetes, decreased heart function,9depleted CoQ10 and vitamin K2 (which are important nutrients), birth defects,10 an increased risk of cancer,11 and nerve damage.12

Statins Still Popular From an Unproved Theory

When this documentary was produced in 2014, at least 40 million people worldwide were taking statins — today, that number is estimated from a low of 100 million13 to as many as 200 million14 — and what was spent annually on statins during their boom was “more than the GNP of some countries,” the documentary claims — and this was no accident.

Thanks to pressure from the drug industry, official guidelines for what constitutes too-high cholesterol are continually being revised downward to recruit more patients and sell more product, says “Heart of the Matter.”

Yet, the harms from statins far outweigh their benefits. They may reduce your chance of heart attacks, but will not improve your general health, Abramson declares in the film. And, in women and the elderly, the risks are especially high, adds Dr. Beatrice Golomb of the University of California at San Diego.

In fact, both Abramson and Golomb agree the overprescription of statins, especially for those who do not need them, is unethical and even “criminal.” When statins first surfaced they were “hailed as nirvana,” Curtis remembers. Today we know they clearly are not.

Have a look at Nitric Oxide Supplement and Heart health and wellness.

Read More

Doctor Warns: Eat Soy and You’ll Look Five Years Older

Top rated Products in support of Heart


Looking for top-quality certified products?  Read about  these special Medically Certified Products.

By Dr. Mercola

In the early 1990’s, soy and soy products exploded onto the supermarket scene with promises of bountiful health benefits.

This “new miracle food,” soy, was supposed to lower cholesterol, take the heat out of hot flashes, protect against breast and prostate cancer, and offer a filling alternative to earth-loving vegetarians.

The problem with these claims?

Most of them are false.

Sadly, most of what you have been led to believe by the media about soy is simply untrue.

The sudden upsurge in the recommendation of soy as a health food has been nothing more than a clever marketing gimmick to further reduce the cost and nutritional content of your food.

For you vegetarians out there staring at the screen in open-mouthed shock, fear not.

There are plenty of other healthy vegetarian alternatives, which I will discuss later in this article.

What was once considered a minor industrial crop back in 1913 now covers over 72 million acres of farmland.

But first, let’s examine the dangers and side effects of soy protein isolate and GMO foods.

Soy Protein Isolate — What Is It, and How Is It Getting in My Food?

The Soyfoods Association of America has a soy protein “fact sheet” defining soy protein isolate as the following:

“Soy protein isolate is a dry powder food ingredient that has been separated or isolated from the other components of the soybean, making it 90 to 95 percent protein and nearly carbohydrate and fat-free.”

Soy protein isolate can be found in protein bars, meal replacement shakes, bottled fruit drinks, soups and sauces, meat analogs, baked goods, breakfast cereals, and some dietary supplements.

Bodybuilders beware: because many weight gainer powders, bars, and shakes contain this dangerous ingredient and it can cause troubling side effects such as diminished libido and erectile dysfunction — and this is just the start. You’ll find out more about these disturbing health effects later on in this article.

Even if you are not a vegetarian and do not use soymilk or tofu, it is important to become a label reader. There are so many different names for soy additives, and you could be bringing home a genetically modified soy-based product without even realizing it. Dr. Daniel offers a free Special Report, “Where the Soys Are,” on her Web site. It lists the many “aliases” that soy might be hiding under in ingredient lists — words like “boullion,” “natural flavor,” and “textured plant protein.”

Here are a few other names soy tends to hide under:

  • Mono-diglyceride
  • Soya, Soja or Yuba
  • TSF (textured soy flour) or TSP (textured soy protein)
  • TVP (textured vegetable protein)
  • Lecithin
  • MSG (monosodium glutamate)

Not all textured vegetable protein is made from soy, but a great deal of it is. Lecithin can be made from soy, eggs, sunflower or corn. Be sure to contact the manufacturer to find out which is in your product if the label doesn’t reveal this information.

GMO — Making Soy Even Worse

One of the worst problems with soy comes from the fact that 90 to 95 percent of soybeans grown in the US are genetically modified (GM), and these are used to create soy protein isolate.

Why the genetic tinkering?

Genetically modified soybeans are designed to be “Roundup ready.” That’s right. They are chemically engineered to withstand heavy doses of herbicides without killing the plant! What does this mean for your health and the health of your unborn or yet-to-be-conceived children? Read on.

GM Soy Can Lead to Hormonal Disruption and Miscarriages

The active ingredient in Roundup herbicide is called glyphosate, which is responsible for the disruption of the delicate hormonal balance of the female reproductive cycle.

“It’s an endocrine buster,” says UK pathologist Stanley Ewen, “that interferes with aromatase, which produces estrogen.”

What’s more, glyphosate is toxic to the placenta, which is responsible for delivering vital nutrients from mother to child, and eliminating waste products. Once the placenta has been damaged or destroyed, the result can be miscarriage. In those children born to mothers who have been exposed to even a small amount of glyphosate, serious birth defects can result.

In an excellent summary of glyphosate-related effects by the Pesticide Action Network1, Dr. Andres Carrasco of the Embryology Laboratory, Faculty of Medicine in Buenos Aires, simply and expertly explains the serious risks for unborn children exposed to Roundup-laden GMO soy products.

Amphibian embryos were exposed to a tiny concentration of glyphosate (diluted 5000 fold) and showed the following effects:

“Effects included reduced head size, genetic alterations in the central nervous system, increased death of cells that help form the skull, deformed cartilage, eye defects, and undeveloped kidneys. Carrasco also stated that the glyphosate was not breaking down in the cells, but was accumulating.

The findings lend weight to claims that abnormally high levels of cancer, birth defects, neonatal mortality, lupus, kidney disease, and skin and respiratory problems in populations near Argentina’s soybean fields may be linked to the aerial spraying of Roundup.”

The long-term effects of the human consumption of genetically modified soy and soy-based products are staggering.

In April 2010, researchers at Russia’s Institute of Ecology and Evolution of the Russian Academy of Sciences and the National Association for Gene Security found that after feeding hamsters GM soy for two years over three generations, by the third generation, most lost the ability to have babies!2  Now, let’s take a close look at some of the health risks to YOU as a result of eating genetically modified soy.

Infertility in Women

Do you want to start a family? Have you had any trouble conceiving, perhaps due to irregular menstrual cycles or endometriosis? Have you ever experienced a miscarriage?

If so, what you’re about to read will shock you.

A Brazilian study published in 20093 looked at the impact of soy on the reproductive system of female rats. Female rats fed GM soy for 15 months showed significant changes in their uterus and reproductive cycles, compared to rats fed organic soy or no soy.

Extrapolating the findings to people, women who eat genetically modified soy products, such as the soy protein isolate in processed vegetarian fare, may be more likely to experience severe hormonal disruptions, including an overabundance of estrogen, a hair-growth stimulating hormone, and damage to the pituitary gland.

According to Dr. Stanley Ewen, the female rats fed GM soy probably had an increase in progesterone4, which could cause an increase in the number of eggs released during each ovulation cycle.

You might think this would lead to an increase in fertility. However, as discussed in an article by Jeffrey Smith, women who consume genetically modified soy products are at increased risk for developing retrograde menstruation (the menstrual cycle backs up into the body instead of outward), causing endometriosis, which can lead to infertility.

The consumption of soy protein isolate and other soy-based products can also lead to abnormally heavy or longer menstrual periods. This is called menorrhagia and, ironically, some commercials have been popping up with a new pill that supposedly offers the “cure” for this “mystery syndrome.”

When in reality the real cure for some women is as simple as removing soy and soy-based products from the diet. The negative effects of soy are not restricted to women, however.

Loss of Libido & Erectile Dysfunction in Men

Guys, do you enjoy protein bars or use a weight-gainer shake? If so, be sure to read the label to see if the products you use contain any soy ingredients. Did you know that celibate monks living in monasteries and leading a vegetarian lifestyle find soy foods quite helpful for dampening libido?5

Another drawback: Soy has also been linked to erectile dysfunction. The two natural drugs found in soy, genistein and daidzein, mimic estrogen so well that they have been known to cause a variety of alarming side effects in men:

  • Breast enlargement (gynecomastia)
  • Decreased facial and body hair growth
  • Decreased libido
  • Mood swings and frequent crying jags
  • Erectile dysfunction
  • Lowered sperm count

For example, one recent study6 documented a case of gynecomastia in a 60-year-old man as a result of his soy consumption. Another study7 showed that juvenile rats exposed to daidzein showed impaired erectile function at maturity.

Men, if you’ve experienced one or any of these symptoms, soy could be the culprit. Remove it from your diet, but be sure to consult a trusted physician if your symptoms do not improve or get worse as this could be a sign of another serious condition.

The Healthy Aspects of Soy: Fermented vs. Unfermented

In order to back up the claim that soy is a health food, privately funded “researchers” have been quick to point out that Asians, who consume a diet high in soy, have less risk of breast, uterine and prostate cancer. Unfortunately, they leave out two very important points:

The reason Asians have an increased risk for some cancers is the same reason they do not develop others: unfermented soy. The soy marketing and promotion gurus left out this critical piece of information. Would you rather have one cancer over another? Isn’t that like asking whether or not you’d like to be whacked in the head with a two-by-four vs. a wooden stick?

You might be asking yourself what the big difference is between consuming a fermented soy product such as, say, tempeh, vs. tofu or a veggie burger. I’m here to tell you, the difference is night and day.

Unfermented AND fermented soy contains hormonal mimics in the form of isoflavones which can not only disrupt delicate hormone systems in your body, but also act as goitrogens, substances that suppress your thyroid function. When the thyroid is suppressed, a host of health problems result, namely:

  • Anxiety and mood swings
  • Insomnia
  • Difficulty losing weight
  • Difficulty conceiving children
  • Digestive problems
  • Food allergies

And so much more. No wonder soy can lead to thyroid, esophagus and stomach cancer! Unfermented soy is also chock full of phytic acid,8 an “antinutrient” responsible for leeching vital nutrients from your body. Phytic acid also blocks the uptake of essential minerals such as calcium, magnesium, copper, iron, and zinc especially.

Now, fermented soy products do provide health benefits.

As I mentioned in my previous article, some examples of healthful fermented soy products are as follows:

  • Tempeh, a fermented soybean cake with a firm texture and nutty, mushroom-like flavor.
  • Miso, a fermented soybean paste with a salty, buttery texture (commonly used in miso soup).
  • Natto, fermented soybeans with a sticky texture and strong, cheese-like flavor.
  • Soy sauce, which is traditionally made by fermenting soybeans, salt and enzymes; be wary because many varieties on the market today are made artificially using a chemical process.

For those of you who enjoy tofu, I’m sorry to say it didn’t make this list because tofu is an unfermented soy product.

So, What Are The Health Benefits of Fermented Soy Products?

The claim that soy products can prevent osteoporosis, decrease your risk of cardiovascular disease and dementia, and protect you from cancer of the prostate, lung, and liver is actually true, but ONLY if the soy is fermented.

How?

The process of fermenting soy destroys the above-mentioned dangerous substances, thereby making it fit for consumption. Also, fermented soy products, such as those listed above, are a rich source of vitamin K2, a vitamin that works in harmony with vitamin D to keep you healthy. Vitamin K regulates your body’s blood clotting ability and helps prevent cancer, osteoporosis and heart disease. And vitamin D is essential to the function of every system in your body.

Warning to Vegetarians About the Risk of Mineral Deficiency

Since phytic acid or phytates sap the nutrients from your body, if you’re eating a vegetarian diet that has replaced meat with mostly unfermented soy such as veggie burgers containing GMO soy protein isolate, you are at risk for severe mineral deficiency.

In addition to this nutrient loss, many processed veggie burgers and the like are packed with harmful artificial flavorings, particularly MSG and textured vegetable protein products to give them their strong “meat” flavor.

What’s even worse is the process soy has to go through to become soy protein isolate. Acid washing in aluminum tanks, which is designed to remove some of the antinutrients (but the results often vary widely), leeches aluminum into the final product. Aluminum can have adverse effects on brain development9 and cause symptoms such as:

  • Antisocial behavior
  • Learning disabilities
  • Alzheimer’s Disease and Dementia10

As I mentioned in a previous article about soy, this makes processed vegetarian fare more palatable, but far from nutritious. Vegetarians have plenty of options for well-rounded, nutritious meals without needing to eat soy or soy-based products.

  • Beans are an inexpensive, protein-rich food that can be eaten alone, added to salads or served as a side dish. Be sure to purchase organic dried beans and cook them at home to avoid the adverse health effects of eating canned food. Ideally, it is also best to soak them for at least 12 hours before cooking them.
  • Nuts are also an excellent source of protein. For optimal health benefits, reach for organic nuts such as almonds or walnuts, instead of overly processed mixed nuts.
  • Quinoa is a gluten free grain that can be enjoyed as a cereal, side dish or added to homemade vegetable stews as a thickener.
  • Flaxseed, which is rich in essential omega-3 fats like ALA, is an excellent source of protein. Add it to salads or sprinkle it over yogurt to infuse your meal with vital nutrients. However, it is important to grind flax seeds just prior to eating them because100 percent of commercially ground flaxseeds are rancid. Hemp seeds11 are also an excellent source of protein.

Hope for the Lactose Intolerant

If you suffer from lactose intolerance and have been replacing milk with soy, you have three more healthful options: Almond milk, and now hemp milk. All are nutritious alternatives to soy, and almond milk has a richer, heartier flavor. Hemp milk12 is a very creamy, high-protein alternative to soymilk, and it’s easy to blend your own by whizzing up hemp seeds and water in a high-speed blender.

Babies — Birth Control in a Bottle

As stated in a number of previous articles, soy formula is one of the most dangerous foods you can feed your baby!

“In 1998, investigators reported that the daily exposure of infants to isoflavones in soy infant formula is 6 to11 times higher on a body-weight basis than the dose that has hormonal effects in adults consuming soy foods. Circulating concentrations of isoflavones in infants fed soy-based formula were 13,000 to 22,000 times higher than plasma estradiol concentrations in infants on cow’s milk formula.”

What does this mean? Feeding your infant soy-based formula can cause a host of health problems including:

  • Behavioral problems
  • Food allergies and digestive distress
  • Early puberty and fertility problems (including the inability to menstruate)
  • Asthma
  • Precocious puberty for girls and gynecomastia (man boobs) for boys
  • Thyroid disease
  • Cancer

As I concluded in my article on infant formula, babies who are fed exclusively from the breast from birth to six months enjoy health benefits such as:

  • Lower risk of respiratory tract and middle ear infections
  • Lower risk of eczema
  • Lower risk of obesity
  • Added protection against heart disease, diabetes, asthma, and allergies
  • Improved brain function and immune system function

Soy formula is also laden with toxic chemicals such as aluminum and manganese, which can cause both physical and mental health problems, learning disabilities, brain damage, and behavioral problems. If, for some reason, you are unable to breastfeed or have adopted a baby, look into these recipes for homemade infant formula.

School Lunch — Children’s Nutrition Left Behind

In order to comply with new US Government standards, soy products are now being used to replace whole, nutritious foods in school lunches. Due to the decreased fat content of soy, it is touted as a healthful alternative to the meat and dairy of yesterday’s hot meal.

Nothing could be further from the truth.

Soy added to your child’s hot lunch depletes the necessary nutrients needed for healthy growth and has been linked to learning disabilities. I encourage you to watch this sobering video to learn more about the dangers in your child’s school lunch. Do your children a favor and send them to school with a healthy, home-packed meal.

Senior Citizens — Aging Less Gracefully

According to a study done by Dr. Lon White13 of the Hawaii Center for Health Research, senior citizens who consumed a lot of tofu in mid-life were more likely to experience accelerated brain aging and a more pronounced loss of cognitive function.

“What’s more,” said Dr. White, “those who ate a lot of tofu, by the time they were 75 or 80, looked five years older.”

If you’re heading toward your golden years and are looking to avoid soy protein, become a label reader. Meal replacement drinks like Ensure are filled with soy protein and are best avoided. As you can see, unfermented soy is anything but a health food.

Do your own research, try eliminating it from your family’s diet and judge the results for yourself. Remember, an educated consumer is an armed consumer. Big companies can only produce and sell these harmful products as long as you’re buying them.

Vote with your wallet by spending your money on healthier alternatives!

Study more about Nitric Oxide and Cardio health.

Read More

Lipid Metabolism in Aging and Age-Related Disease

Top Supplements for Heart


Hunting for top quality endorsed quality products?  Read and learn about  these special Medically Endorsed Supplements.

Lipids are everywhere in our biochemistry. Where they are present in cell structures and molecular mechanisms that are important to any specific age-related disease, or are among the underlying root causes of aging, it will tend to be the case that differences between species (and possibly individuals) can lead to changes in the pace of aging and disease. For example, lipid composition determines resistance to oxidative damage to cell membranes. A range of evidence supports the membrane pacemaker hypothesis of aging, in that longer-lived species tend to have more resilient cell membranes, based on their lipid composition.

Today’s open access paper uses lipids as an anchoring point for a wide-ranging discussion on aging, biomarkers of aging, and the differences in aging between species. The authors are, I feel, justifiably pessimistic about the prospects for the eventual production of therapies based on most of the means to slow aging demonstrated in short-lived laboratory species. There are indeed radical differences between the biochemistry of short-lived species and long-lived species such as our own. Yet even when mechanisms are in fact proven to be much the same in all of worms, flies, mice, and humans, as is the case for calorie restriction and its upregulation of cellular maintenance processes, we cannot expect that therapies will automatically be effective enough to justify development. The practice of calorie restriction extends life in mice by up to 40%, but while it improves health in humans, it certainly doesn’t significantly extend human life span in the same way.

The role of lipid metabolism in aging, lifespan regulation, and age-related disease


Due to the sheer amount of time and cost required to validate a study in humans, the bulk of our aging and lifespan data come from shorter-lived yeast, worms, flies, and rodents. With the exception of research showing that caloric restriction improves health and survival in rhesus monkeys, little aging work has been done in longer-lived organisms. The bulk of our understanding regarding aging comes from genetic experiments in model organisms, and we do not yet know how similar or dissimilar human aging is. Rather than screen every lifespan-extending intervention in humans to better understand how human aging works, another approach would be to utilize aging biomarkers.

Biomarkers that strongly correlate with aging, lifespan, and healthspan can teach us about which processes are involved in human aging. Ideally, a robust and practical biomarker would be one that incurs a low monetary cost and can be measured safely, repeatedly, and easily. Blood draws are especially appealing because they are inexpensive, simple, low risk, and can be taken as needed throughout a patient’s lifetime. While several biomarker studies have focused on protein-based markers, the advancement of metabolomic techniques has made it feasible to look closely into a large array of metabolites. Metabolomic lipids and lipid-related proteins represent a large, rich source of potential biomarkers that are easily measured in the blood. Compounds in lipid metabolism can take many forms, such as phospholipids, triglycerides, waxes, steroids, and fatty acids. They also play diverse physiological roles, such as forming cell membranes and exerting powerful cell signaling effects. Lipids are perhaps the most well-known for the paramount roles they play in both the storage and mobilization of energy.

Although lipids have been traditionally treated as detrimental and as simply associated with age-related diseases, numerous studies have shown that lipid metabolism potently regulates aging and lifespan. For example, researchers assessed the plasma lipidomic profiles of 11 different mammalian species with longevities varying from 3.5 to 120 years. They found that a lipidomic profile could accurately predict an animal’s lifespan and that, in particular, plasma long-chain free fatty acids, peroxidizability index, and lipid peroxidation-derived product content are inversely correlated with longevity. Evidence from animals with extreme longevity also links lipid metabolism to aging. The ocean quahog clam Arctica islandica, an exceptionally long-lived animal that can survive for more than 500 years, exhibits a unique resistance to lipid peroxidation in mitochondrial membranes. Naked mole rats, which enjoy remarkably long lifespans and healthspans for rodents, have a unique membrane phospholipid composition that has been theorized to contribute to their exceptional longevity.

A plethora of dietary, pharmacological, genetic, and surgical lipid-related interventions extend lifespan in nematodes, fruit flies, mice, and rats. For example, the impairment of genes involved in ceramide and sphingolipid synthesis extends lifespan in both worms and flies. The overexpression of fatty acid amide hydrolase or lysosomal lipase prolongs life in Caenorhabditis elegans, while the overexpression of diacylglycerol lipase enhances longevity in both C. elegans and Drosophila melanogaster. The surgical removal of adipose tissue extends lifespan in rats, and increased expression of apolipoprotein D enhances survival in both flies and mice. Mouse lifespan can be additionally extended by the genetic deletion of diacylglycerol acyltransferase 1, treatment with the steroid 17-α-estradiol, or a ketogenic diet.

In humans, blood triglyceride levels tend to increase, while blood lysophosphatidylcholine levels tend to decrease with age. Specific sphingolipid and phospholipid blood profiles have also been shown to change with age and are associated with exceptional human longevity. These data suggest that lipid-related interventions may improve human healthspan and that blood lipids likely represent a rich source of human aging biomarkers.

Have a look at Nitric Oxide and Cardio health.

Read More